1
|
Louro H, Vettorazzi A, López de Cerain A, Spyropoulou A, Solhaug A, Straumfors A, Behr AC, Mertens B, Žegura B, Fæste CK, Ndiaye D, Spilioti E, Varga E, Dubreil E, Borsos E, Crudo F, Eriksen GS, Snapkow I, Henri J, Sanders J, Machera K, Gaté L, Le Hegarat L, Novak M, Smith NM, Krapf S, Hager S, Fessard V, Kohl Y, Silva MJ, Dirven H, Dietrich J, Marko D. Hazard characterization of Alternaria toxins to identify data gaps and improve risk assessment for human health. Arch Toxicol 2024; 98:425-469. [PMID: 38147116 PMCID: PMC10794282 DOI: 10.1007/s00204-023-03636-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2023] [Accepted: 11/09/2023] [Indexed: 12/27/2023]
Abstract
Fungi of the genus Alternaria are ubiquitous plant pathogens and saprophytes which are able to grow under varying temperature and moisture conditions as well as on a large range of substrates. A spectrum of structurally diverse secondary metabolites with toxic potential has been identified, but occurrence and relative proportion of the different metabolites in complex mixtures depend on strain, substrate, and growth conditions. This review compiles the available knowledge on hazard identification and characterization of Alternaria toxins. Alternariol (AOH), its monomethylether AME and the perylene quinones altertoxin I (ATX-I), ATX-II, ATX-III, alterperylenol (ALP), and stemphyltoxin III (STTX-III) showed in vitro genotoxic and mutagenic properties. Of all identified Alternaria toxins, the epoxide-bearing analogs ATX-II, ATX-III, and STTX-III show the highest cytotoxic, genotoxic, and mutagenic potential in vitro. Under hormone-sensitive conditions, AOH and AME act as moderate xenoestrogens, but in silico modeling predicts further Alternaria toxins as potential estrogenic factors. Recent studies indicate also an immunosuppressive role of AOH and ATX-II; however, no data are available for the majority of Alternaria toxins. Overall, hazard characterization of Alternaria toxins focused, so far, primarily on the commercially available dibenzo-α-pyrones AOH and AME and tenuazonic acid (TeA). Limited data sets are available for altersetin (ALS), altenuene (ALT), and tentoxin (TEN). The occurrence and toxicological relevance of perylene quinone-based Alternaria toxins still remain to be fully elucidated. We identified data gaps on hazard identification and characterization crucial to improve risk assessment of Alternaria mycotoxins for consumers and occupationally exposed workers.
Collapse
Affiliation(s)
- Henriqueta Louro
- Department of Human Genetics, National Institute of Health Dr. Ricardo Jorge (INSA) and Centre for Toxicogenomics and Human Health (ToxOmics), NOVA Medical School, Universidade Nova de Lisboa, Av. Padre Cruz, 1649-016, Lisbon, Portugal
| | - Ariane Vettorazzi
- MITOX Research Group, Department of Pharmaceutical Sciences, Faculty of Pharmacy and Nutrition, UNAV-University of Navarra, Pamplona, Spain
| | - Adela López de Cerain
- MITOX Research Group, Department of Pharmaceutical Sciences, Faculty of Pharmacy and Nutrition, UNAV-University of Navarra, Pamplona, Spain
| | - Anastasia Spyropoulou
- Laboratory of Toxicological Control of Pesticides, Scientific Directorate of Pesticides' Control and Phytopharmacy, Benaki Phytopathological Institute, 145 61, Attica, Greece
| | - Anita Solhaug
- Norwegian Veterinary Institute, PO Box 64, 1431, Ås, Norway
| | | | - Anne-Cathrin Behr
- Department Food Safety, BfR, German Federal Institute for Risk Assessment, Max-Dohrnstraße 8-10, 10589, Berlin, Germany
| | - Birgit Mertens
- Department of Chemical and Physical Health Risks, Sciensano, Brussels, Belgium
| | - Bojana Žegura
- Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna Pot 111, 1000, Ljubljana, Slovenia
| | | | - Dieynaba Ndiaye
- INRS, Institut National de Recherche et de Sécurité pour la Prévention des accidents du travail et des maladies professionnelles, Rue du Morvan, CS 60027, 54519, Vandœuvre Lès Nancy Cedex, France
| | - Eliana Spilioti
- Laboratory of Toxicological Control of Pesticides, Scientific Directorate of Pesticides' Control and Phytopharmacy, Benaki Phytopathological Institute, 145 61, Attica, Greece
| | - Elisabeth Varga
- Department of Food Chemistry and Toxicology, Faculty of Chemistry, University of Vienna, Vienna, Austria
- Food Hygiene and Technology, University of Veterinary Medicine, Vienna, Veterinärplatz 1, 1210, Vienna, Austria
| | - Estelle Dubreil
- Toxicology of Contaminants Unit, Fougères Laboratory, French Agency for Food, Environmental and Occupational Health and Safety, 10 B rue Claude Bourgelat, 35306, Fougères, France
| | - Eszter Borsos
- Food Hygiene and Technology, University of Veterinary Medicine, Vienna, Veterinärplatz 1, 1210, Vienna, Austria
| | - Francesco Crudo
- Food Hygiene and Technology, University of Veterinary Medicine, Vienna, Veterinärplatz 1, 1210, Vienna, Austria
| | | | - Igor Snapkow
- Department of Chemical Toxicology, Norwegian Institute of Public Health, Lovisenberggate 8, 0456, Oslo, Norway
| | - Jérôme Henri
- Toxicology of Contaminants Unit, Fougères Laboratory, French Agency for Food, Environmental and Occupational Health and Safety, 10 B rue Claude Bourgelat, 35306, Fougères, France
| | - Julie Sanders
- Department of Chemical and Physical Health Risks, Sciensano, Brussels, Belgium
| | - Kyriaki Machera
- Laboratory of Toxicological Control of Pesticides, Scientific Directorate of Pesticides' Control and Phytopharmacy, Benaki Phytopathological Institute, 145 61, Attica, Greece
| | - Laurent Gaté
- INRS, Institut National de Recherche et de Sécurité pour la Prévention des accidents du travail et des maladies professionnelles, Rue du Morvan, CS 60027, 54519, Vandœuvre Lès Nancy Cedex, France
| | - Ludovic Le Hegarat
- Toxicology of Contaminants Unit, Fougères Laboratory, French Agency for Food, Environmental and Occupational Health and Safety, 10 B rue Claude Bourgelat, 35306, Fougères, France
| | - Matjaž Novak
- Department of Genetic Toxicology and Cancer Biology, National Institute of Biology, Večna Pot 111, 1000, Ljubljana, Slovenia
| | - Nicola M Smith
- Department of Chemical Toxicology, Norwegian Institute of Public Health, Lovisenberggate 8, 0456, Oslo, Norway
| | - Solveig Krapf
- Norwegian Veterinary Institute, PO Box 64, 1431, Ås, Norway
| | - Sonja Hager
- Department of Food Chemistry and Toxicology, Faculty of Chemistry, University of Vienna, Vienna, Austria
| | - Valérie Fessard
- Toxicology of Contaminants Unit, Fougères Laboratory, French Agency for Food, Environmental and Occupational Health and Safety, 10 B rue Claude Bourgelat, 35306, Fougères, France
| | - Yvonne Kohl
- Fraunhofer Institute for Biomedical Engineering IBMT, Joseph-Von-Fraunhofer-Weg 1, 66280, Sulzbach, Germany
| | - Maria João Silva
- Department of Human Genetics, National Institute of Health Dr. Ricardo Jorge (INSA) and Centre for Toxicogenomics and Human Health (ToxOmics), NOVA Medical School, Universidade Nova de Lisboa, Av. Padre Cruz, 1649-016, Lisbon, Portugal
| | - Hubert Dirven
- Department of Chemical Toxicology, Norwegian Institute of Public Health, Lovisenberggate 8, 0456, Oslo, Norway
| | - Jessica Dietrich
- Department Safety in the Food Chain, BfR, German Federal Institute for Risk Assessment, Max-Dohrn-Straße 8-10, 10589, Berlin, Germany
| | - Doris Marko
- Department of Food Chemistry and Toxicology, Faculty of Chemistry, University of Vienna, Vienna, Austria.
| |
Collapse
|
2
|
Collia M, Møller P, Langie SAS, Vettorazzi A, Azqueta A. Further development of CometChip technology to measure DNA damage in vitro and in vivo: Comparison with the 2 gels/slide format of the standard and enzyme-modified comet assay. Toxicology 2024; 501:153690. [PMID: 38040084 DOI: 10.1016/j.tox.2023.153690] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2023] [Revised: 11/17/2023] [Accepted: 11/27/2023] [Indexed: 12/03/2023]
Abstract
DNA damage plays a pivotal role in carcinogenesis and other diseases. The comet assay has been used for more than three decades to measure DNA damages. The 1-2 gels/slide format is the most used version of the assay. In 2010, a high throughput 96 macrowell format with a spatially encoded array of microwells patterned in agarose was developed, called the CometChip. The commercial version (CometChip®) has been used for the in vitro standard version of the comet assay (following the manufacturer's protocol), although it has not been compared directly with the 2 gels/slide format. The aim of this work is to developed new protocols to allow use of DNA repair enzymes as well as the analysis of in vivo frozen tissue samples in the CometChip®, to increase the throughput, and to compare its performance with the classic 2 gels/slide format. We adapted the manufacturer's protocol to allow the use of snap frozen tissue samples, using male Wistar rats orally dosed with methyl methanesulfonate (MMS, 200 mg/kg b.w.), and to detect altered nucleobases using DNA repair enzymes, with TK6 cells treated with potassium bromate (KBrO3, 0-4 mM, 3 h) and formamidopyrimidine DNA glycosylase (Fpg) as the enzyme. Regarding the standard version of the comet, we performed thee comparison of the 2 gel/slide and CometChip® format (using the the manufacturer's protocol), using TK6 cells with MMS (100-800 µM, 1 h) and hydrogen peroxide (H2O2, 7.7-122.5 µM, 5 min) as testing compounds. In all cases the CometChip® was performed along with the 2 gels/slide format. Results obtained were comparable and the CometChip® is a good alternative to the 2 gels/slide format when a higher throughput is required.
Collapse
Affiliation(s)
- Miguel Collia
- Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain
| | - Peter Møller
- Department of Public Health, Section of Environmental Health, University of Copenhagen, Copenhagen, Denmark
| | - Sabine A S Langie
- Department of Pharmacology & Toxicology, School for Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Maastricht, the Netherlands
| | - Ariane Vettorazzi
- Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain
| | - Amaya Azqueta
- Department of Pharmaceutical Sciences, School of Pharmacy and Nutrition, University of Navarra, Pamplona, Spain.
| |
Collapse
|
3
|
Al-Ayoubi C, Alonso-Jauregui M, Azqueta A, Vignard J, Mirey G, Rocher O, Puel O, Oswald IP, Vettorazzi A, Soler L. Mutagenicity and genotoxicity assessment of the emerging mycotoxin Versicolorin A, an Aflatoxin B1 precursor. Environ Pollut 2023; 335:122276. [PMID: 37517643 DOI: 10.1016/j.envpol.2023.122276] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/31/2023] [Revised: 07/25/2023] [Accepted: 07/26/2023] [Indexed: 08/01/2023]
Abstract
Aflatoxin B1 (AFB1) is the most potent natural carcinogen among mycotoxins. Versicolorin A (VerA) is a precursor of AFB1 biosynthesis and is structurally related to the latter. Although VerA has already been identified as a genotoxin, data on the toxicity of VerA are still scarce, especially at low concentrations. The SOS/umu and miniaturised version of the Ames test in Salmonella Typhimurium strains used in the present study shows that VerA induces point mutations. This effect, like AFB1, depends primarily on metabolic activation of VerA. VerA also induced chromosomal damage in metabolically competent intestinal cells (IPEC-1) detected by the micronucleus assay. Furthermore, results from the standard and enzyme-modified comet assay confirmed the VerA-mediated DNA damage, and we observed that DNA repair pathways were activated upon exposure to VerA, as indicated by the phosphorylation and/or relocation of relevant DNA-repair biomarkers (γH2AX and 53BP1/FANCD2, respectively). In conclusion, VerA induces DNA damage without affecting cell viability at concentrations as low as 0.03 μM, highlighting the danger associated with VerA exposure and calling for more research on the carcinogenicity of this emerging food contaminant.
Collapse
Affiliation(s)
- Carine Al-Ayoubi
- Toxalim (Research Centre in Food Toxicology), University of Toulouse, INRAE, ENVT, INP-Purpan, UPS, 31027, Toulouse, France
| | - Maria Alonso-Jauregui
- Department of Pharmacology and Toxicology, Research Group MITOX, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain
| | - Amaya Azqueta
- Department of Pharmacology and Toxicology, Research Group MITOX, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain
| | - Julien Vignard
- Toxalim (Research Centre in Food Toxicology), University of Toulouse, INRAE, ENVT, INP-Purpan, UPS, 31027, Toulouse, France
| | - Gladys Mirey
- Toxalim (Research Centre in Food Toxicology), University of Toulouse, INRAE, ENVT, INP-Purpan, UPS, 31027, Toulouse, France
| | - Ophelie Rocher
- Toxalim (Research Centre in Food Toxicology), University of Toulouse, INRAE, ENVT, INP-Purpan, UPS, 31027, Toulouse, France
| | - Olivier Puel
- Toxalim (Research Centre in Food Toxicology), University of Toulouse, INRAE, ENVT, INP-Purpan, UPS, 31027, Toulouse, France
| | - Isabelle P Oswald
- Toxalim (Research Centre in Food Toxicology), University of Toulouse, INRAE, ENVT, INP-Purpan, UPS, 31027, Toulouse, France
| | - Ariane Vettorazzi
- Department of Pharmacology and Toxicology, Research Group MITOX, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain
| | - Laura Soler
- Toxalim (Research Centre in Food Toxicology), University of Toulouse, INRAE, ENVT, INP-Purpan, UPS, 31027, Toulouse, France.
| |
Collapse
|
4
|
Alonso-Jauregui M, López de Cerain A, Azqueta A, Rodriguez-Garraus A, Gil AG, González-Peñas E, Vettorazzi A. In Vivo Genotoxicity and Toxicity Assessment of Sterigmatocystin Individually and in Mixture with Aflatoxin B1. Toxins (Basel) 2023; 15:491. [PMID: 37624248 PMCID: PMC10467059 DOI: 10.3390/toxins15080491] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2023] [Revised: 07/21/2023] [Accepted: 08/01/2023] [Indexed: 08/26/2023] Open
Abstract
Mycotoxins are natural food and feed contaminants produced by several molds. The primary mode of exposure in humans and animals is through mixtures. Aflatoxin B1 (AFB1) and sterigmatocystin (STER) are structurally related mycotoxins that share the same biosynthetic route. Few in vivo genotoxicity assays have been performed with STER. In the present genotoxicity study, Wistar rats were dosed orally with STER (20 mg/kg b.w.), AFB1 (0.25 mg/kg b.w.) or a mixture of both in an integrated micronucleus (bone marrow) and comet study (liver and kidney). STER was dosed at the highest feasible dose in corn oil. No increase in the percentage of micronuclei in bone marrow was observed at any condition. Slight DNA damage was detected in the livers of animals treated with AFB1 or the mixture (DNA strand breaks and Fpg (Formamidopyrimidine DNA glycosylase)-sensitive sites, respectively). Plasma, liver, and kidney samples were analyzed with LC-MS/MS demonstrating exposure to both mycotoxins. General toxicity parameters (organs absolute weight, biochemistry, and histopathology) were not altered either individually or in the mixture. The overall absence of individual genotoxicity did not allow us to set any type of interaction in the mixture. However, a possible toxicokinetic interaction was observed.
Collapse
Affiliation(s)
- Maria Alonso-Jauregui
- MITOX Research Group, Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain; (M.A.-J.); (A.L.d.C.); (A.A.); (A.R.-G.); (A.G.G.)
| | - Adela López de Cerain
- MITOX Research Group, Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain; (M.A.-J.); (A.L.d.C.); (A.A.); (A.R.-G.); (A.G.G.)
| | - Amaya Azqueta
- MITOX Research Group, Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain; (M.A.-J.); (A.L.d.C.); (A.A.); (A.R.-G.); (A.G.G.)
| | - Adriana Rodriguez-Garraus
- MITOX Research Group, Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain; (M.A.-J.); (A.L.d.C.); (A.A.); (A.R.-G.); (A.G.G.)
| | - Ana Gloria Gil
- MITOX Research Group, Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain; (M.A.-J.); (A.L.d.C.); (A.A.); (A.R.-G.); (A.G.G.)
| | - Elena González-Peñas
- MITOX Research Group, Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain;
| | - Ariane Vettorazzi
- MITOX Research Group, Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, University of Navarra, 31008 Pamplona, Spain; (M.A.-J.); (A.L.d.C.); (A.A.); (A.R.-G.); (A.G.G.)
| |
Collapse
|
5
|
Audebert M, Assmann AS, Azqueta A, Babica P, Benfenati E, Bortoli S, Bouwman P, Braeuning A, Burgdorf T, Coumoul X, Debizet K, Dusinska M, Ertych N, Fahrer J, Fetz V, Le Hégarat L, López de Cerain A, Heusinkveld HJ, Hogeveen K, Jacobs MN, Luijten M, Raitano G, Recoules C, Rundén-Pran E, Saleh M, Sovadinová I, Stampar M, Thibol L, Tomkiewicz C, Vettorazzi A, Van de Water B, El Yamani N, Zegura B, Oelgeschläger M. New approach methodologies to facilitate and improve the hazard assessment of non-genotoxic carcinogens-a PARC project. Front Toxicol 2023; 5:1220998. [PMID: 37492623 PMCID: PMC10364052 DOI: 10.3389/ftox.2023.1220998] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2023] [Accepted: 06/19/2023] [Indexed: 07/27/2023] Open
Abstract
Carcinogenic chemicals, or their metabolites, can be classified as genotoxic or non-genotoxic carcinogens (NGTxCs). Genotoxic compounds induce DNA damage, which can be detected by an established in vitro and in vivo battery of genotoxicity assays. For NGTxCs, DNA is not the primary target, and the possible modes of action (MoA) of NGTxCs are much more diverse than those of genotoxic compounds, and there is no specific in vitro assay for detecting NGTxCs. Therefore, the evaluation of the carcinogenic potential is still dependent on long-term studies in rodents. This 2-year bioassay, mainly applied for testing agrochemicals and pharmaceuticals, is time-consuming, costly and requires very high numbers of animals. More importantly, its relevance for human risk assessment is questionable due to the limited predictivity for human cancer risk, especially with regard to NGTxCs. Thus, there is an urgent need for a transition to new approach methodologies (NAMs), integrating human-relevant in vitro assays and in silico tools that better exploit the current knowledge of the multiple processes involved in carcinogenesis into a modern safety assessment toolbox. Here, we describe an integrative project that aims to use a variety of novel approaches to detect the carcinogenic potential of NGTxCs based on different mechanisms and pathways involved in carcinogenesis. The aim of this project is to contribute suitable assays for the safety assessment toolbox for an efficient and improved, internationally recognized hazard assessment of NGTxCs, and ultimately to contribute to reliable mechanism-based next-generation risk assessment for chemical carcinogens.
Collapse
Affiliation(s)
- Marc Audebert
- INRAE: Toxalim, INRAE, INP-ENVT, INP-EI-Purpan, Université de Toulouse 3 Paul Sabatier, Toulouse, France
| | - Ann-Sophie Assmann
- Department Experimental Toxicology and ZEBET, German Centre for the Protection of Laboratory Animals (Bf3R) and Department Food Safety, BfR: German Federal Institute for Risk Assessment, Berlin, Germany
| | - Amaya Azqueta
- Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, UNAV: University of Navarra, Pamplona, Spain
| | - Pavel Babica
- RECETOX: RECETOX, Faculty of Science, Masaryk University, Brno, Czechia
| | - Emilio Benfenati
- IRFMN: Istituto di Ricerche Farmacologiche Mario Negri—IRCCS, Milan, Italy
| | - Sylvie Bortoli
- INSERM: INSERM UMR-S 1124 T3S—Université Paris Cité, Paris, France
| | - Peter Bouwman
- UL-LACDR: Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands
| | - Albert Braeuning
- Department Experimental Toxicology and ZEBET, German Centre for the Protection of Laboratory Animals (Bf3R) and Department Food Safety, BfR: German Federal Institute for Risk Assessment, Berlin, Germany
| | - Tanja Burgdorf
- Department Experimental Toxicology and ZEBET, German Centre for the Protection of Laboratory Animals (Bf3R) and Department Food Safety, BfR: German Federal Institute for Risk Assessment, Berlin, Germany
| | - Xavier Coumoul
- INSERM: INSERM UMR-S 1124 T3S—Université Paris Cité, Paris, France
| | - Kloé Debizet
- INSERM: INSERM UMR-S 1124 T3S—Université Paris Cité, Paris, France
| | - Maria Dusinska
- Health Effects Laboratory, NILU: The Climate and Environmental Research Institute, Kjeller, Norway
| | - Norman Ertych
- Department Experimental Toxicology and ZEBET, German Centre for the Protection of Laboratory Animals (Bf3R) and Department Food Safety, BfR: German Federal Institute for Risk Assessment, Berlin, Germany
| | - Jörg Fahrer
- Department of Chemistry, RPTU: Division of Food Chemistry and Toxicology, Kaiserslautern, Germany
| | - Verena Fetz
- Department Experimental Toxicology and ZEBET, German Centre for the Protection of Laboratory Animals (Bf3R) and Department Food Safety, BfR: German Federal Institute for Risk Assessment, Berlin, Germany
| | - Ludovic Le Hégarat
- ANSES: French Agency for Food, Environmental and Occupational Health and Safety, Fougères Laboratory, Toxicology of Contaminants Unit, Fougères, France
| | - Adela López de Cerain
- Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, UNAV: University of Navarra, Pamplona, Spain
| | - Harm J. Heusinkveld
- RIVM: National Institute for Public Health and the Environment, Bilthoven, Netherlands
| | - Kevin Hogeveen
- ANSES: French Agency for Food, Environmental and Occupational Health and Safety, Fougères Laboratory, Toxicology of Contaminants Unit, Fougères, France
| | - Miriam N. Jacobs
- Radiation, Chemical and Environmental Hazards, UKHSA: UK Health Security Agency, Chilton, Oxfordshire, United Kingdom
| | - Mirjam Luijten
- RIVM: National Institute for Public Health and the Environment, Bilthoven, Netherlands
| | - Giuseppa Raitano
- IRFMN: Istituto di Ricerche Farmacologiche Mario Negri—IRCCS, Milan, Italy
| | - Cynthia Recoules
- INRAE: Toxalim, INRAE, INP-ENVT, INP-EI-Purpan, Université de Toulouse 3 Paul Sabatier, Toulouse, France
| | - Elise Rundén-Pran
- Health Effects Laboratory, NILU: The Climate and Environmental Research Institute, Kjeller, Norway
| | - Mariam Saleh
- ANSES: French Agency for Food, Environmental and Occupational Health and Safety, Fougères Laboratory, Toxicology of Contaminants Unit, Fougères, France
| | - Iva Sovadinová
- RECETOX: RECETOX, Faculty of Science, Masaryk University, Brno, Czechia
| | - Martina Stampar
- Department of Genetic Toxicology and Cancer Biology, NIB: National Institute of Biology, Ljubljana, Slovenia
| | - Lea Thibol
- Department of Chemistry, RPTU: Division of Food Chemistry and Toxicology, Kaiserslautern, Germany
| | | | - Ariane Vettorazzi
- Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, UNAV: University of Navarra, Pamplona, Spain
| | - Bob Van de Water
- UL-LACDR: Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands
| | - Naouale El Yamani
- Health Effects Laboratory, NILU: The Climate and Environmental Research Institute, Kjeller, Norway
| | - Bojana Zegura
- Department of Genetic Toxicology and Cancer Biology, NIB: National Institute of Biology, Ljubljana, Slovenia
| | - Michael Oelgeschläger
- Department Experimental Toxicology and ZEBET, German Centre for the Protection of Laboratory Animals (Bf3R) and Department Food Safety, BfR: German Federal Institute for Risk Assessment, Berlin, Germany
| |
Collapse
|
6
|
Alonso-Jauregui M, González-Peñas E, López de Cerain A, Vettorazzi A. Genotoxicity of 12 Mycotoxins by the SOS/umu Test: Comparison of Liver and Kidney S9 Fraction. Toxins (Basel) 2022; 14:400. [PMID: 35737061 PMCID: PMC9228656 DOI: 10.3390/toxins14060400] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2022] [Revised: 06/02/2022] [Accepted: 06/07/2022] [Indexed: 12/10/2022] Open
Abstract
Liver S9 fraction is usually employed in mutagenicity/genotoxicity in vitro assays, but some genotoxic compounds may need another type of bioactivation. In the present work, an alternative S9 fraction from the kidneys was used for the genotoxicity assessment of 12 mycotoxins with the SOS/umu test. The results were compared with liver S9 fraction, and 2-4 independent experiments were performed with each mycotoxin. The expected results were obtained with positive controls (4-nitroquinoline-N-oxide and 2-aminoanthracene) without metabolic activation or with liver S9, but a potent dose-dependent effect with 4-nitroquinoline-N-oxide and no activity of 2-aminoanthracene with kidney S9 were noticed. Aflatoxin B1 was genotoxic with metabolic activation, the effect being greater with liver S9. Sterigmatocystin was clearly genotoxic with liver S9 but equivocal with kidney S9. Ochratoxin A, zearalenone and fumonisin B1 were negative in all conditions. Trichothecenes were negative, except for nivalenol, 3-acetyldeoxynivalenol, 15-acetyldeoxynivalenol, T-2 and HT-2 toxins, which showed equivocal results with kidney S9 because a clear dose-response effect was not observed. Most of the mycotoxins have been assessed with kidney S9 and the SOS/umu test for the first time here. The results with the positive controls and the mycotoxins confirm that the organ used for the S9 fraction preparation has an influence on the genotoxic activity of some compounds.
Collapse
Affiliation(s)
- Maria Alonso-Jauregui
- MITOX Research Group, Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain; (M.A.-J.); (A.L.d.C.)
| | - Elena González-Peñas
- MITOX Research Group, Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain;
| | - Adela López de Cerain
- MITOX Research Group, Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain; (M.A.-J.); (A.L.d.C.)
| | - Ariane Vettorazzi
- MITOX Research Group, Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain; (M.A.-J.); (A.L.d.C.)
| |
Collapse
|
7
|
Alonso-Jauregui M, Font M, González-Peñas E, López de Cerain A, Vettorazzi A. Prioritization of Mycotoxins Based on Their Genotoxic Potential with an In Silico-In Vitro Strategy. Toxins (Basel) 2021; 13:734. [PMID: 34679027 PMCID: PMC8540412 DOI: 10.3390/toxins13100734] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2021] [Revised: 10/08/2021] [Accepted: 10/12/2021] [Indexed: 11/16/2022] Open
Abstract
Humans are widely exposed to a great variety of mycotoxins and their mixtures. Therefore, it is important to design strategies that allow prioritizing mycotoxins based on their toxic potential in a time and cost-effective manner. A strategy combining in silico tools (Phase 1), including an expert knowledge-based (DEREK Nexus®, Lhasa Limited, Leeds, UK) and a statistical-based platform (VEGA QSAR©, Mario Negri Institute, Milan, Italy), followed by the in vitro SOS/umu test (Phase 2), was applied to a set of 12 mycotoxins clustered according to their structure into three groups. Phase 1 allowed us to clearly classify group 1 (aflatoxin and sterigmatocystin) as mutagenic and group 3 (ochratoxin A, zearalenone and fumonisin B1) as non-mutagenic. For group 2 (trichothecenes), contradictory conclusions were obtained between the two in silico tools, being out of the applicability domain of many models. Phase 2 confirmed the results obtained in the previous phase for groups 1 and 3. It also provided extra information regarding the role of metabolic activation in aflatoxin B1 and sterigmatocystin mutagenicity. Regarding group 2, equivocal results were obtained in few experiments; however, the group was finally classified as non-mutagenic. The strategy used correlated with the published Ames tests, which detect point mutations. Few alerts for chromosome aberrations could be detected. The SOS/umu test appeared as a good screening test for mutagenicity that can be used in the absence and presence of metabolic activation and independently of Phase 1, although the in silico-in vitro combination gave more information for decision making.
Collapse
Affiliation(s)
- Maria Alonso-Jauregui
- Department of Pharmacology and Toxicology, Research Group MITOX, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain; (M.A.-J.); (A.L.d.C.)
| | - María Font
- Department of Pharmaceutical Technology and Chemistry, Research Group MITOX, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain; (M.F.); (E.G.-P.)
- IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain
| | - Elena González-Peñas
- Department of Pharmaceutical Technology and Chemistry, Research Group MITOX, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain; (M.F.); (E.G.-P.)
| | - Adela López de Cerain
- Department of Pharmacology and Toxicology, Research Group MITOX, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain; (M.A.-J.); (A.L.d.C.)
- IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain
| | - Ariane Vettorazzi
- Department of Pharmacology and Toxicology, Research Group MITOX, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain; (M.A.-J.); (A.L.d.C.)
- IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain
| |
Collapse
|
8
|
Vettorazzi A, Izco M, Gonzz-Penas E, Lopez de Cerain A, Alvarez-Erviti L. Is ochratoxin A a potential neurodegenerative toxin?: mechanistic in vitro and in vivo studies. Toxicol Lett 2021. [DOI: 10.1016/s0378-4274(21)00569-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
9
|
Méndez DA, Fabra MJ, Falcó I, Sánchez G, Aranaz P, Vettorazzi A, Ribas-Agustí A, González-Navarro CJ, Castellari M, Martínez-Abad A, López-Rubio A. Bioactive extracts from persimmon waste: influence of extraction conditions and ripeness. Food Funct 2021; 12:7428-7439. [PMID: 34190270 DOI: 10.1039/d1fo00457c] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
In this work, a bioactive persimmon extract was produced from discarded fruits. A central composite design was used to evaluate the effect of different extraction parameters and ripeness stages of persimmon fruits on the total phenolic content and antioxidant activity of the resulting extracts. Significantly greater phenolic contents were obtained from immature persimmon (IP) fruits. The optimum IP extract with the conditions set by the experimental design was industrially up-scaled and its composition and functional properties were evaluated and compared with those obtained under lab-scale conditions. Both extracts contained significant protein (>20%) and phenolic contents (∼11-27 mg GA/g dry extract) and displayed significant antiviral activity against murine norovirus and hepatitis A virus. Moreover, the extract showed no toxicity and significantly reduced the fat content and the cellular ageing of Caenorhabditis elegans (C. elegans) without affecting the worm development. These effects were mediated by down-regulation of fat-7, suggesting an anti-lipogenic activity of this extract.
Collapse
Affiliation(s)
- Daniel Alexander Méndez
- Food Safety and Preservation Department, Institute of Agrochemistry and Food Technology (IATA-CSIC), Valencia, Spain.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Muruzabal D, Sanz-Serrano J, Sauvaigo S, Treillard B, Olsen AK, López de Cerain A, Vettorazzi A, Azqueta A. Validation of the in vitro comet assay for DNA cross-links and altered bases detection. Arch Toxicol 2021; 95:2825-2838. [PMID: 34196753 PMCID: PMC8298235 DOI: 10.1007/s00204-021-03102-3] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2021] [Accepted: 06/15/2021] [Indexed: 11/27/2022]
Abstract
Mechanistic toxicology is gaining weight for human health risk assessment. Different mechanistic assays are available, such as the comet assay, which detects DNA damage at the level of individual cells. However, the conventional alkaline version only detects strand breaks and alkali-labile sites. We have validated two modifications of the in vitro assay to generate mechanistic information: (1) use of DNA-repair enzymes (i.e., formamidopyrimidine DNA glycosylase, endonuclease III, human 8-oxoguanine DNA glycosylase I and human alkyladenine DNA glycosylase) for detection of oxidized and alkylated bases as well as (2) a modification for detecting cross-links. Seven genotoxicants with different mechanisms of action (potassium bromate, methyl methanesulfonate, ethyl methanesulfonate, hydrogen peroxide, cisplatin, mitomycin C, and benzo[a]pyrene diol epoxide), as well as a non-genotoxic compound (dimethyl sulfoxide) and a cytotoxic compound (Triton X-100) were tested on TK-6 cells. We were able to detect with high sensitivity and clearly differentiate oxidizing, alkylating and cross-linking agents. These modifications of the comet assay significantly increase its sensitivity and its specificity towards DNA lesions, providing mechanistic information regarding the type of damage.
Collapse
Affiliation(s)
- Damián Muruzabal
- Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31009, Pamplona, Spain
| | - Julen Sanz-Serrano
- Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31009, Pamplona, Spain
| | - Sylvie Sauvaigo
- LXRepair, Biopolis, 5 Avenue du Grand Sablon, 38700, La Tronche, France
| | | | - Ann-Karin Olsen
- Section of Molecular Toxicology, Department of Environmental Health, Norwegian Institute of Public Health, Skøyen, PO Box 222, 0213, Oslo, Norway
| | - Adela López de Cerain
- Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31009, Pamplona, Spain
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
| | - Ariane Vettorazzi
- Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31009, Pamplona, Spain.
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
| | - Amaya Azqueta
- Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31009, Pamplona, Spain
- IdiSNA, Navarra Institute for Health Research, Pamplona, Spain
| |
Collapse
|
11
|
Arce-López B, Alvarez-Erviti L, De Santis B, Izco M, López-Calvo S, Marzo-Sola ME, Debegnach F, Lizarraga E, López de Cerain A, González-Peñas E, Vettorazzi A. Biomonitoring of Mycotoxins in Plasma of Patients with Alzheimer's and Parkinson's Disease. Toxins (Basel) 2021; 13:toxins13070477. [PMID: 34357949 PMCID: PMC8310068 DOI: 10.3390/toxins13070477] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2021] [Revised: 06/29/2021] [Accepted: 07/02/2021] [Indexed: 12/24/2022] Open
Abstract
Exposure to environmental contaminants might play an important role in neurodegenerative disease pathogenesis, such as Parkinson´s disease (PD) and Alzheimer´s disease (AD). For the first time in Spain, the plasmatic levels of 19 mycotoxins from patients diagnosed with a neurodegenerative disease (44 PD and 24 AD) and from their healthy companions (25) from La Rioja region were analyzed. The studied mycotoxins were aflatoxins B1, B2, G1, G2 and M1, T-2 and HT-2, ochratoxins A (OTA) and B (OTB), zearalenone, sterigmatocystin (STER), nivalenol, deoxynivalenol, 3-acetyldeoxynivalenol, 15-acetyldeoxynivalenol, deepoxy-deoxynivalenol, neosolaniol, diacetoxyscirpenol and fusarenon-X. Samples were analyzed by LC-MS/MS before and after treatment with β-glucuronidase/arylsulfatase in order to detect potential metabolites. Only OTA, OTB and STER were detected in the samples. OTA was present before (77% of the samples) and after (89%) the enzymatic treatment, while OTB was only detectable before (13%). Statistically significant differences in OTA between healthy companions and patients were observed but the observed differences might seem more related to gender (OTA levels higher in men, p-value = 0.0014) than the disease itself. STER appeared only after enzymatic treatment (88%). Statistical analysis on STER, showed distributions always different between healthy controls and patients (patients’ group > controls, p-value < 0.0001). Surprisingly, STER levels weakly correlated positively with age in women (rho = 0.3384), while OTA correlation showed a decrease of levels with age especially in the men with PD (rho = −0.4643).
Collapse
Affiliation(s)
- Beatriz Arce-López
- Department of Pharmaceutical Technology and Chemistry, Research Group MITOX, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain; (B.A.-L.); (E.L.); (E.G.-P.)
| | - Lydia Alvarez-Erviti
- Laboratory of Molecular Neurobiology, Center for Biomedical Research of La Rioja (CIBIR), Piqueras 98, 3rd Floor, 26006 Logroño, Spain; (L.A.-E.); (M.I.)
| | - Barbara De Santis
- National Reference Laboratory for Mycotoxins and Plant Toxins, Istituto Superiore di Sanità, 00161 Roma, Italy; (B.D.S.); (F.D.)
| | - María Izco
- Laboratory of Molecular Neurobiology, Center for Biomedical Research of La Rioja (CIBIR), Piqueras 98, 3rd Floor, 26006 Logroño, Spain; (L.A.-E.); (M.I.)
| | - Silvia López-Calvo
- Servicio de Neurología, Hospital San Pedro, Piqueras 98, 26006 Logroño, Spain; (S.L.-C.); (M.E.M.-S.)
| | - Maria Eugenia Marzo-Sola
- Servicio de Neurología, Hospital San Pedro, Piqueras 98, 26006 Logroño, Spain; (S.L.-C.); (M.E.M.-S.)
| | - Francesca Debegnach
- National Reference Laboratory for Mycotoxins and Plant Toxins, Istituto Superiore di Sanità, 00161 Roma, Italy; (B.D.S.); (F.D.)
| | - Elena Lizarraga
- Department of Pharmaceutical Technology and Chemistry, Research Group MITOX, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain; (B.A.-L.); (E.L.); (E.G.-P.)
| | - Adela López de Cerain
- Department of Pharmacology and Toxicology, Research Group MITOX, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain;
- IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain
| | - Elena González-Peñas
- Department of Pharmaceutical Technology and Chemistry, Research Group MITOX, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain; (B.A.-L.); (E.L.); (E.G.-P.)
| | - Ariane Vettorazzi
- Department of Pharmacology and Toxicology, Research Group MITOX, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain;
- IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain
- Correspondence:
| |
Collapse
|
12
|
Izco M, Vettorazzi A, Forcen R, Blesa J, de Toro M, Alvarez-Herrera N, Cooper JM, Gonzalez-Peñas E, Lopez de Cerain A, Alvarez-Erviti L. Oral subchronic exposure to the mycotoxin ochratoxin A induces key pathological features of Parkinson's disease in mice six months after the end of the treatment. Food Chem Toxicol 2021; 152:112164. [PMID: 33819549 DOI: 10.1016/j.fct.2021.112164] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2021] [Revised: 03/25/2021] [Accepted: 03/29/2021] [Indexed: 12/19/2022]
Abstract
Some epidemiological studies with different levels of evidence have pointed to a higher risk of Parkinson's disease (PD) after exposure to environmental toxicants. A practically unexplored potential etiological factor is a group of naturally-occurring fungal secondary metabolites called mycotoxins. The mycotoxin ochratoxin A (OTA) has been reported to be neurotoxic in mice. To further identify if OTA exposure could have a role in PD pathology, Balb/c mice were orally treated with OTA (0.21, 0.5 mg/kg bw) four weeks and left for six months under normal diet. Effects of OTA on the onset, progression of alpha-synuclein pathology and development of motor deficits were evaluated. Immunohistochemical and biochemical analyses showed that oral subchronic OTA treatment induced loss of striatal dopaminergic innervation and dopaminergic cell dysfunction responsible for motor impairments. Phosphorylated alpha-synuclein levels were increased in gut and brain. LAMP-2A protein was decreased in tissues showing alpha-synuclein pathology. Cell cultures exposed to OTA exhibited decreased LAMP-2A protein, impairment of chaperone-mediated autophagy and decreased alpha-synuclein turnover which was linked to miRNAs deregulation, all reminiscent of PD. These results support the hypothesis that oral exposure to low OTA doses in mice can lead to biochemical and pathological changes reported in PD.
Collapse
Affiliation(s)
- María Izco
- Laboratory of Molecular Neurobiology, Center for Biomedical Research of La Rioja (CIBIR), Piqueras 98, 3rd Floor, 26006, Logroño, Spain.
| | - Ariane Vettorazzi
- Department of Pharmacology and Toxicology, MITOX Research Group, Universidad de Navarra, Pamplona, 31008, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, 31008, Spain.
| | - Raquel Forcen
- Laboratory of Molecular Neurobiology, Center for Biomedical Research of La Rioja (CIBIR), Piqueras 98, 3rd Floor, 26006, Logroño, Spain.
| | - Javier Blesa
- HM CINAC, Hospital Universitario HM Puerta del Sur, Av. Carlos V, 70, 28938, Móstoles, Madrid, Spain.
| | - Maria de Toro
- Genomics and Bioinformatics Core Facility, Center for Biomedical Research of La Rioja (CIBIR), Logroño, Spain.
| | - Natalia Alvarez-Herrera
- Laboratory of Molecular Neurobiology, Center for Biomedical Research of La Rioja (CIBIR), Piqueras 98, 3rd Floor, 26006, Logroño, Spain.
| | - J Mark Cooper
- Department of Clinical and Movement Neuroscience, Institute of Neurology, UCL, Gower Street, London, UK.
| | - Elena Gonzalez-Peñas
- Department of Pharmaceutical Technology and Chemistry, Universidad de Navarra, Pamplona, 31008, Spain.
| | - Adela Lopez de Cerain
- Department of Pharmacology and Toxicology, MITOX Research Group, Universidad de Navarra, Pamplona, 31008, Spain; IdiSNA, Navarra Institute for Health Research, Pamplona, 31008, Spain.
| | - Lydia Alvarez-Erviti
- Laboratory of Molecular Neurobiology, Center for Biomedical Research of La Rioja (CIBIR), Piqueras 98, 3rd Floor, 26006, Logroño, Spain.
| |
Collapse
|
13
|
Sanz-Serrano J, Vettorazzi A, Muruzabal D, López de Cerain A, Azqueta A. In vitro genotoxicity assessment of functional ingredients: DHA, rutin and α-tocopherol. Food Chem Toxicol 2021; 153:112237. [PMID: 33894296 DOI: 10.1016/j.fct.2021.112237] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2021] [Revised: 03/31/2021] [Accepted: 04/16/2021] [Indexed: 11/26/2022]
Abstract
The in vitro genotoxicity of three compounds widely used as functional ingredients, docosahexaenoic acid (DHA), rutin and α-tocopherol, was assessed. A miniaturized version of the Ames test in Salmonella typhimurium TA97a, TA98, TA100, TA102, and TA1535 strains (following the principles of OECD 471), and the in vitro micronucleus test in TK6 cells (OECD 487) were performed. This strategy is recommended by the European Food Safety Authority for the in vitro genotoxicity assessment of food and feed. In addition, this approach was complemented with the in vitro standard and enzyme-modified comet assay (S9-/S9+) using hOGG1, EndoIII and hAAG in order to assess potential premutagenic lesions in TK6 cells. Rutin showed an equivocal response in the in vitro micronucleus test and also was a potent Salmonella typhimurium revertant inductor in the Ames test. DHA showed equivocal results in the in vitro micronucleus test. In this regard, DHA and rutin seemed to interact with the DNA at a chromosomal level, but rutin is also capable of producing frameshift mutations. No genotoxicity was observed in cells treated with α-tocopherol. This article complements the evidence already available about the genotoxicity of these compounds. However, more studies are needed in order to elucidate the consequences of their use as functional ingredients in human health.
Collapse
Affiliation(s)
- Julen Sanz-Serrano
- Universidad de Navarra, School of Pharmacy and Nutrition, Department of Pharmacology and Toxicology, Irunlarrea 1, 31008, Pamplona, Spain
| | - Ariane Vettorazzi
- Universidad de Navarra, School of Pharmacy and Nutrition, Department of Pharmacology and Toxicology, Irunlarrea 1, 31008, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Irunlarrea 3, 31008, Pamplona, Spain
| | - Damian Muruzabal
- Universidad de Navarra, School of Pharmacy and Nutrition, Department of Pharmacology and Toxicology, Irunlarrea 1, 31008, Pamplona, Spain
| | - Adela López de Cerain
- Universidad de Navarra, School of Pharmacy and Nutrition, Department of Pharmacology and Toxicology, Irunlarrea 1, 31008, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Irunlarrea 3, 31008, Pamplona, Spain.
| | - Amaya Azqueta
- Universidad de Navarra, School of Pharmacy and Nutrition, Department of Pharmacology and Toxicology, Irunlarrea 1, 31008, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Irunlarrea 3, 31008, Pamplona, Spain
| |
Collapse
|
14
|
Pastor L, Vettorazzi A, Guruceaga E, López de Cerain A. Time Course of Renal Transcriptomics after Subchronic Exposure to Ochratoxin A in Fisher Rats. Toxins (Basel) 2021; 13:177. [PMID: 33652839 PMCID: PMC7996782 DOI: 10.3390/toxins13030177] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2021] [Revised: 02/16/2021] [Accepted: 02/20/2021] [Indexed: 12/21/2022] Open
Abstract
The mycotoxin ochratoxin A (OTA) is a potent nephrocarcinogen, mainly in male rats. The aim of this study was to determine the time course of gene expression (GeneChip® Rat Gene 2.0 ST Array, Affymetrix) in kidney samples from male and female F344 rats, treated daily (p.o) with 0.50 mg/kg b.w. (body weight) of OTA for 7 or 21 days, and evaluate if there were differences between both sexes. After OTA treatment, there was an evolution of gene expression in the kidney over time, with more differentially expressed genes (DEG) at 21 days. The gene expression time course was different between sexes with respect to the number of DEG and the direction of expression (up or down): the female response was progressive and consistent over time, whereas males had a different early response with more DEG, most of them up-regulated. The statistically most significant DEG corresponded to metabolism enzymes (Akr1b7, Akr1c2, Adh6 down-regulated in females; Cyp2c11, Dhrs7, Cyp2d1, Cyp2d5 down-regulated in males) or transporters (Slc17a9 down-regulated in females; Slco1a1 (OATP-1) and Slc51b and Slc22a22 (OAT) down-regulated in males). Some of these genes had also a basal sex difference and were over-expressed in males or females with respect to the other sex.
Collapse
Affiliation(s)
- Laura Pastor
- Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, University of Navarra, CIFA Building, c/Irunlarrea 1, E-31008 Pamplona, Spain; (L.P.); (A.L.d.C.)
- IdiSNA, Navarra Institute for Health Research, E-31008 Pamplona, Spain;
| | - Ariane Vettorazzi
- Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, University of Navarra, CIFA Building, c/Irunlarrea 1, E-31008 Pamplona, Spain; (L.P.); (A.L.d.C.)
- IdiSNA, Navarra Institute for Health Research, E-31008 Pamplona, Spain;
| | - Elizabeth Guruceaga
- IdiSNA, Navarra Institute for Health Research, E-31008 Pamplona, Spain;
- Bioinformatics Platform, Center for Applied Medical Research (CIMA), University of Navarra, E-31008 Pamplona, Spain
| | - Adela López de Cerain
- Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, University of Navarra, CIFA Building, c/Irunlarrea 1, E-31008 Pamplona, Spain; (L.P.); (A.L.d.C.)
- IdiSNA, Navarra Institute for Health Research, E-31008 Pamplona, Spain;
| |
Collapse
|
15
|
Sanz-Serrano J, Vettorazzi A, Muruzabal D, Azqueta A, López de Cerain A. In Vitro Genotoxicity Assessment of Functional Ingredients: Betaine, Choline, and Taurine. Foods 2021; 10:339. [PMID: 33562510 PMCID: PMC7915792 DOI: 10.3390/foods10020339] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2021] [Revised: 01/26/2021] [Accepted: 01/28/2021] [Indexed: 12/21/2022] Open
Abstract
This article focuses on a complete in vitro genotoxicity assessment of three nutrients widely used as functional ingredients in the European market: betaine, choline, and taurine. The European Food Safety Authority (EFSA) tiered approach for food additives in concordance with the safety assessment of chemicals in food developed by Food and Agriculture Organization/World Health Organization (FAO/WHO) was followed; the miniaturized Ames test in Salmonella typhimurium TA97a, TA98, TA100, TA102, and TA1535 strains (following the principles of Organization for Economic Co-operation and Development (OECD) 471), and the micronucleus test (OECD 487) in TK6 cells were performed. In addition, the in vitro standard and enzyme-modified (human 8-oxoguanine DNA glycosylase 1 (hOGG), endonuclease III (EndoIII), human alkyladenine DNA glycosylase (hAAG)) comet assay (S9-/S9+) was conducted in order to assess the potential premutagenic lesions in TK6 cells. None of the compounds produced any signs of genotoxicity in any of the conditions tested. This article increases the limited evidence available and complements the EFSA recommendations for the in vitro genotoxicity testing of nutrients.
Collapse
Affiliation(s)
- Julen Sanz-Serrano
- Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, Universidad de Navarra, Irunlarrea 1, 31008 Pamplona, Spain; (J.S.-S.); (A.V.); (D.M.); (A.L.d.C.)
| | - Ariane Vettorazzi
- Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, Universidad de Navarra, Irunlarrea 1, 31008 Pamplona, Spain; (J.S.-S.); (A.V.); (D.M.); (A.L.d.C.)
- Navarra Institute for Health Research, IdiSNA, Irunlarrea 3, 31008 Pamplona, Spain
| | - Damian Muruzabal
- Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, Universidad de Navarra, Irunlarrea 1, 31008 Pamplona, Spain; (J.S.-S.); (A.V.); (D.M.); (A.L.d.C.)
| | - Amaya Azqueta
- Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, Universidad de Navarra, Irunlarrea 1, 31008 Pamplona, Spain; (J.S.-S.); (A.V.); (D.M.); (A.L.d.C.)
- Navarra Institute for Health Research, IdiSNA, Irunlarrea 3, 31008 Pamplona, Spain
| | - Adela López de Cerain
- Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, Universidad de Navarra, Irunlarrea 1, 31008 Pamplona, Spain; (J.S.-S.); (A.V.); (D.M.); (A.L.d.C.)
- Navarra Institute for Health Research, IdiSNA, Irunlarrea 3, 31008 Pamplona, Spain
| |
Collapse
|
16
|
Izco M, Vettorazzi A, de Toro M, Sáenz Y, Alvarez-Erviti L. Oral Sub-chronic Ochratoxin A Exposure Induces Gut Microbiota Alterations in Mice. Toxins (Basel) 2021; 13:106. [PMID: 33535685 PMCID: PMC7912851 DOI: 10.3390/toxins13020106] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2021] [Revised: 01/26/2021] [Accepted: 01/28/2021] [Indexed: 01/11/2023] Open
Abstract
Gut microbiota plays crucial roles in maintaining host health. External factors, such as diet, medicines, and environmental toxins, influence the composition of gut microbiota. Ochratoxin A (OTA) is one of the most prevalent and relevant mycotoxins and is a highly abundant food and animal feed contaminant. In the present study, we aimed to investigate OTA gut microbiome toxicity in mice sub-chronically exposed to low doses of OTA (0.21, 0.5, and 1.5 mg/kg body weight) by daily oral gavage for 28 days. Fecal microbiota from control and OTA-treated mice was analyzed using 16S ribosomal RNA (rRNA) gene sequencing followed by metagenomics. OTA exposure caused marked changes in gut microbial community structure, including the decrease in the diversity of fecal microbiota and the relative abundance of Firmicutes, as well as the increase in the relative abundance of Bacteroidetes at the phylum level. At the family level, six bacterial families (unclassified Bacteroidales, Porphyromonadaceae, unclassified Cyanobacteria, Streptococcaceae, Enterobacteriaceae, Ruminococcaceae) were significantly altered by OTA exposure. Interestingly, OTA-induced changes were observed in the lower-dose OTA groups, while high-dose OTA group microbiota was similar to control group. Our results demonstrated that sub-chronic exposure at low doses of OTA alters the structure and diversity of the gut microbial community.
Collapse
Affiliation(s)
- María Izco
- Laboratory of Molecular Neurobiology, Center for Biomedical Research of La Rioja (CIBIR), 26006 Logroño, Spain;
| | - Ariane Vettorazzi
- MITOX Group, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Universidad de Navarra, 31008 Pamplona, Spain;
- IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain
| | - Maria de Toro
- Center for Biomedical Research of La Rioja (CIBIR), Genomics and Bioinformatics Core Facility, 26006 Logroño, Spain;
| | - Yolanda Sáenz
- Molecular Microbiology Area, Center for Biomedical Research of La Rioja (CIBIR), 26006 Logroño, Spain;
| | - Lydia Alvarez-Erviti
- Laboratory of Molecular Neurobiology, Center for Biomedical Research of La Rioja (CIBIR), 26006 Logroño, Spain;
| |
Collapse
|
17
|
Muruzabal D, Sanz-Serrano J, Sauvaigo S, Gützkow KB, de Cerain AL, Vettorazzi A, Azqueta A. Corrigendum to "Novel approach for the detection of alkylated bases using the enzyme-modified comet assay" [Toxicol. Lett. 330 (2020) 108-117]. Toxicol Lett 2020; 335:98. [PMID: 33172770 DOI: 10.1016/j.toxlet.2020.10.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- Damián Muruzabal
- Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31009, Pamplona, Spain
| | - Julen Sanz-Serrano
- Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31009, Pamplona, Spain
| | - Sylvie Sauvaigo
- LXRepair, Biopolis, 5 Avenue du Grand Sablon, 38700, La Tronche, France
| | - Kristine B Gützkow
- Section of Molecular Toxicology, Department of Environmental Health, Norwegian Institute of Public Health, P.O. Box 222, Skøyen, 0213, Oslo, Norway
| | - Adela López de Cerain
- Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31009, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Spain
| | - Ariane Vettorazzi
- Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31009, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Spain
| | - Amaya Azqueta
- Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31009, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Spain.
| |
Collapse
|
18
|
Muruzabal D, Sanz-Serrano J, Sauvaigo S, Gützkow KB, López de Cerain A, Vettorazzi A, Azqueta A. Novel approach for the detection of alkylated bases using the enzyme-modified comet assay. Toxicol Lett 2020; 330:108-117. [PMID: 32380118 DOI: 10.1016/j.toxlet.2020.04.021] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2020] [Revised: 04/06/2020] [Accepted: 04/24/2020] [Indexed: 12/26/2022]
Abstract
The enzyme-modified comet assay is widely used for the detection of oxidized DNA lesions. Here we describe for the first time the use of the human alkyladenine DNA glycosylase (hAAG) for the detection of alkylated bases. hAAG was titrated using untreated and methyl methanesulfonate (MMS)-treated TK-6 cells. The hAAG-modified comet assay was compared to the formamidopyrimidine DNA glycosylase (Fpg)-modified comet assay, widely used to detect oxidized lesions but that also detects ring-opened purines derived from some alkylated lesions, using cells treated with potassium bromate (oxidizing agent) or MMS. Moreover, neutral and alkaline lysis conditions were used to determine the nature of detected lesions. When alkaline lysis was employed (condition normally used), the level of hAAG-sensitive sites was higher than the Fpg-sensitive sites in MMS-treated cells and hAAG, unlike Fpg, did not detect oxidized bases. After neutral lysis, Fpg did not detect MMS-induced lesions; however, results obtained with hAAG remained unchanged. As expected, Fpg detected oxidized purines and imidazole ring-opened purines, derived from N7-methylguanines under alkaline conditions. It seems that hAAG detected N7-methylguanines, the ring-opened purines derived at high pH, and 3-methlyladenines. Specificity of hAAG towards different DNA lesions was evaluated using a multiplex oligonucleotide-cleavage assay, confirming the ability of hAAG to detect ethenoadenines and hypoxanthine. The hAAG-modified comet assay is a new tool for the detection of alkylated bases.
Collapse
Affiliation(s)
- Damián Muruzabal
- Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31009 Pamplona, Spain
| | - Julen Sanz-Serrano
- Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31009 Pamplona, Spain
| | - Sylvie Sauvaigo
- LXRepair, Biopolis, 5 avenue du Grand Sablon, 38700 La Tronche, France
| | - Kristine B Gützkow
- Section of Molecular Toxicology, Department of Environmental Health, Norwegian Institute of Public Health, P.O. Box 222, Skøyen, 0213 Oslo, Norway
| | - Adela López de Cerain
- Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31009 Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Spain
| | - Ariane Vettorazzi
- Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31009 Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Spain
| | - Amaya Azqueta
- Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31009 Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Spain.
| |
Collapse
|
19
|
Collins A, Vettorazzi A, Azqueta A. The role of the enzyme-modified comet assay in in vivo studies. Toxicol Lett 2020; 327:58-68. [PMID: 32247831 DOI: 10.1016/j.toxlet.2020.03.016] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2020] [Revised: 03/18/2020] [Accepted: 03/20/2020] [Indexed: 12/24/2022]
Abstract
The in vivo comet assay is an established genotoxicity test, with an OECD test guideline, but in its standard form it measures only DNA strand breaks. Including in the assay an additional step, in which the DNA is incubated with a lesion-specific enzyme, can provide important information about the nature of the DNA damage. Formamidopyrimidine DNA glycosylase, 8-oxoguanine DNA glycosylase or endonuclease III are commonly used in the in vitro genotoxicity test and in human biomonitoring to detect oxidised bases, but in vivo applications are rarer. A systematic literature search has identified a total of 60 papers that report such in vivo experiments, testing a variety of agents. In many cases, strand breaks were not seen, but significant levels of enzyme-sensitive sites were induced - indicating a mechanism of action involving oxidative stress. Compounds such as methyl methanesulfonate (MMS) or ethyl methanesulfonate (EMS) could be used as positive controls in both the standard and the enzyme-modified in vivo comet assays.
Collapse
Affiliation(s)
- Andrew Collins
- Department of Nutrition, Institute for Basic Medical Sciences, University of Oslo, Sognsvannsveien 9, 0372, Oslo, Norway
| | - Ariane Vettorazzi
- Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31009, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, Spain
| | - Amaya Azqueta
- Department of Pharmacology and Toxicology, University of Navarra, C/Irunlarrea 1, 31009, Pamplona, Spain.
| |
Collapse
|
20
|
Arce-López B, Lizarraga E, Vettorazzi A, González-Peñas E. Human Biomonitoring of Mycotoxins in Blood, Plasma and Serum in Recent Years: A Review. Toxins (Basel) 2020; 12:E147. [PMID: 32121036 PMCID: PMC7150965 DOI: 10.3390/toxins12030147] [Citation(s) in RCA: 47] [Impact Index Per Article: 11.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2020] [Revised: 02/14/2020] [Accepted: 02/25/2020] [Indexed: 12/17/2022] Open
Abstract
This manuscript reviews the state-of-the-art regarding human biological monitoring (HBM) of mycotoxins in plasma serum and blood samples. After a comprehensive and systematic literature review, with a focus on the last five years, several aspects were analyzed and summarized: a) the biomarkers analyzed and their encountered levels, b) the analytical methodologies developed and c) the relationship between biomarker levels and some illnesses. In the literature reviewed, aflatoxin B1-lysine (AFB1-lys) and ochratoxin A (OTA) in plasma and serum were the most widely studied mycotoxin biomarkers for HBM. Regarding analytical methodologies, a clear increase in the development of methods for the simultaneous determination of multiple mycotoxins has been observed. For this purpose, the use of liquid chromatography (LC) methodologies, especially when coupled with tandem mass spectrometry (MS/MS) or high resolution mass spectrometry (HRMS), has grown. A high percentage of the samples analyzed for OTA or aflatoxin B1 (mostly as AFB1-lys) in the reviewed papers were positive, demonstrating human exposure to mycotoxins. This review confirms the importance of mycotoxin human biomonitoring and highlights the important challenges that should be faced, such as the inclusion of other mycotoxins in HBM programs, the need to increase knowledge of mycotoxin metabolism and toxicokinetics, and the need for reference materials and new methodologies for treating samples. In addition, guidelines are required for analytical method validation, as well as equations to establish the relationship between human fluid levels and mycotoxin intake.
Collapse
Affiliation(s)
- Beatriz Arce-López
- Department of Pharmaceutical Technology and Chemistry; Universidad de Navarra, 31008 Pamplona, Navarra, Spain; (B.A.-L.); (E.G.-P.)
| | - Elena Lizarraga
- Department of Pharmaceutical Technology and Chemistry; Universidad de Navarra, 31008 Pamplona, Navarra, Spain; (B.A.-L.); (E.G.-P.)
| | - Ariane Vettorazzi
- Department of Pharmacology and Toxicology. School of Pharmacy and Nutrition, 31008 Pamplona, Navarra, Spain;
- IdiSNA, Institute for Health Research, 31008 Pamplona, Navarra, Spain
| | - Elena González-Peñas
- Department of Pharmaceutical Technology and Chemistry; Universidad de Navarra, 31008 Pamplona, Navarra, Spain; (B.A.-L.); (E.G.-P.)
| |
Collapse
|
21
|
Vettorazzi A, López de Cerain A, Sanz-Serrano J, Gil AG, Azqueta A. European Regulatory Framework and Safety Assessment of Food-Related Bioactive Compounds. Nutrients 2020; 12:E613. [PMID: 32110982 PMCID: PMC7146632 DOI: 10.3390/nu12030613] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2020] [Accepted: 02/19/2020] [Indexed: 12/13/2022] Open
Abstract
A great variety of functional foods, nutraceuticals, or foods with bioactive compounds are provided nowadays to consumers. Aware of the importance of the safety aspects, the food industry has to comply with different legal requirements around the world. In this review, the European regulatory framework for food-related bioactive compounds is summarized. The term 'bioactive compound' is not defined in the European regulations, however, since they can be part of food supplements, fortified foods, or novel food, they are included within the legal requirements of those corresponding types of foods or supplements. Lists of authorized compounds/foods appear in the correspondent regulations, however, when a new compound/food is going to be launched into the market, its safety assessment is essential. Although the responsibility for the safety of these compounds/foods lies with the food business operator placing the product on the market, the European Food Safety Authority (EFSA) carries out scientific evaluations to assess the risks for human health. To facilitate this procedure, different guidelines exist at the European level to explain the tier toxicity testing approach to be considered. This approach divides the evaluation into four areas: (a) toxicokinetics; (b) genotoxicity; (c) subchronic and chronic toxicity and carcinogenicity; and (d) reproductive and developmental toxicity.
Collapse
Affiliation(s)
- Ariane Vettorazzi
- Department of Pharmacology and Toxicology, University of Navarra, 31008 Pamplona, Spain; (A.L.d.C.); (J.S.-S.); (A.G.G.); (A.A.)
- IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain
| | - Adela López de Cerain
- Department of Pharmacology and Toxicology, University of Navarra, 31008 Pamplona, Spain; (A.L.d.C.); (J.S.-S.); (A.G.G.); (A.A.)
- IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain
| | - Julen Sanz-Serrano
- Department of Pharmacology and Toxicology, University of Navarra, 31008 Pamplona, Spain; (A.L.d.C.); (J.S.-S.); (A.G.G.); (A.A.)
| | - Ana G. Gil
- Department of Pharmacology and Toxicology, University of Navarra, 31008 Pamplona, Spain; (A.L.d.C.); (J.S.-S.); (A.G.G.); (A.A.)
- IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain
| | - Amaya Azqueta
- Department of Pharmacology and Toxicology, University of Navarra, 31008 Pamplona, Spain; (A.L.d.C.); (J.S.-S.); (A.G.G.); (A.A.)
- IdiSNA, Navarra Institute for Health Research, 31008 Pamplona, Spain
| |
Collapse
|
22
|
Sanz-Serrano J, López de Cerain A, Garayoa R, Azqueta A, Vettorazzi A. Genotoxicity evaluation of fried meat: A comprehensive review. Food Chem Toxicol 2020; 136:110943. [DOI: 10.1016/j.fct.2019.110943] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2019] [Revised: 10/31/2019] [Accepted: 11/02/2019] [Indexed: 01/11/2023]
|
23
|
Rodriguez-Garraus A, Azqueta A, Vettorazzi A, López de Cerain A. Genotoxicity of Silver Nanoparticles. Nanomaterials (Basel) 2020; 10:E251. [PMID: 32023837 PMCID: PMC7075128 DOI: 10.3390/nano10020251] [Citation(s) in RCA: 43] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/27/2019] [Revised: 01/22/2020] [Accepted: 01/24/2020] [Indexed: 12/18/2022]
Abstract
Silver nanoparticles (AgNPs) are widely used in diverse sectors such as medicine, food, cosmetics, household items, textiles and electronics. Given the extent of human exposure to AgNPs, information about the toxicological effects of such products is required to ensure their safety. For this reason, we performed a bibliographic review of the genotoxicity studies carried out with AgNPs over the last six years. A total of 43 articles that used well-established standard assays (i.e., in vitro mouse lymphoma assays, in vitro micronucleus tests, in vitro comet assays, in vivo micronucleus tests, in vivo chromosome aberration tests and in vivo comet assays), were selected. The results showed that AgNPs produce genotoxic effects at all DNA damage levels evaluated, in both in vitro and in vivo assays. However, a higher proportion of positive results was obtained in the in vitro studies. Some authors observed that coating and size had an effect on both in vitro and in vivo results. None of the studies included a complete battery of assays, as recommended by ICH and EFSA guidelines, and few of the authors followed OECD guidelines when performing assays. A complete genotoxicological characterization of AgNPs is required for decision-making.
Collapse
Affiliation(s)
- Adriana Rodriguez-Garraus
- Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, Universidad de Navarra, Irunlarrea 1, 31008 Pamplona, Spain; (A.R.-G.); (A.V.); (A.L.d.C.)
| | - Amaya Azqueta
- Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, Universidad de Navarra, Irunlarrea 1, 31008 Pamplona, Spain; (A.R.-G.); (A.V.); (A.L.d.C.)
- Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain
| | - Ariane Vettorazzi
- Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, Universidad de Navarra, Irunlarrea 1, 31008 Pamplona, Spain; (A.R.-G.); (A.V.); (A.L.d.C.)
- Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain
| | - Adela López de Cerain
- Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, Universidad de Navarra, Irunlarrea 1, 31008 Pamplona, Spain; (A.R.-G.); (A.V.); (A.L.d.C.)
- Navarra Institute for Health Research (IdiSNA), 31008 Pamplona, Spain
| |
Collapse
|
24
|
González-Peñas E, Vettorazzi A, Lizarraga E, Azqueta A, López de Cerain A. Report of the IVth Workshop of the Spanish National Network on Mycotoxins and Toxigenic Fungi and Their Decontamination Processes (MICOFOOD), Held in Pamplona, Spain, 29-31 May 2019. Toxins (Basel) 2019; 11:toxins11070415. [PMID: 31315277 PMCID: PMC6669504 DOI: 10.3390/toxins11070415] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2019] [Accepted: 07/12/2019] [Indexed: 11/23/2022] Open
Abstract
The present publication collects the communications presented in the IV Workshop of the Spanish National Network on Mycotoxins and Toxigenic Fungi and their Decontamination Processes (MICOFOOD), held in the School of Pharmacy and Nutrition of the Universidad de Navarra (Pamplona, Spain) from the 29 to the 31 May 2019. More than 70 professionals from academia, the industry and public services have participated. The scientific program included: five sessions: sponsors (presentation and services), toxigenic fungi, toxicology, analysis and control, and reduction and prevention strategies. In total, 18 oral communications and 24 posters were presented. It is worth mentioning the high participation and quality of the communications from PhD students. The invited conference, entitled: “Mycotoxins within the framework of exposure assessment: past present and future”, was given by Dr. Barbara de Santis (Istituto Superiore di Sanità, Rome, Italy). The meeting ended with the roundtable: “From feed to fork: safe food without mycotoxins”, where representatives of feed and agrofood companies and public administrations discussed about the current situation and problems related with mycotoxins. Different prizes were awarded for the best oral presentation (Effect of Staphylococcus xylosus on the growth of toxigenic moulds in meat substrates, by E. Cebrian et al., University of Extremadura), and the best posters (Combined toxicity of aflatoxins and ochratoxin A: A systematic review by M. Alonso-Jaúregui et al., Universidad de Navarra; and Application of natamycin in products affected by toxigenic fungi by Torrijos et al., Universitat de València). The participants had the opportunity to learn about the history and gastronomy of Pamplona. Situated in the north of Spain, Pamplona is a city of Roman origin featuring a large gothic cathedral complex and a Vauban citadel of the 16th century.
Collapse
Affiliation(s)
- Elena González-Peñas
- Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain.
| | - Ariane Vettorazzi
- Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain
- IdiSNA, Navarra Institute for Health Research,31008 Pamplona, Spain
| | - Elena Lizarraga
- Department of Pharmaceutical Technology and Chemistry, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain
| | - Amaya Azqueta
- Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain
- IdiSNA, Navarra Institute for Health Research,31008 Pamplona, Spain
| | - Adela López de Cerain
- Department of Pharmacology and Toxicology, School of Pharmacy and Nutrition, Universidad de Navarra, 31008 Pamplona, Spain
- IdiSNA, Navarra Institute for Health Research,31008 Pamplona, Spain
| |
Collapse
|
25
|
Vettorazzi A, Pastor L, Guruceaga E, López de Cerain A. Sex-dependent gene expression after ochratoxin A insult in F344 rat kidney. Food Chem Toxicol 2018; 123:337-348. [PMID: 30449730 DOI: 10.1016/j.fct.2018.10.057] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2018] [Revised: 10/19/2018] [Accepted: 10/24/2018] [Indexed: 02/02/2023]
Abstract
Ochratoxin A (OTA) is a potent rodent nephrocarcinogen; being males more sensitive than females. The objective was to study the response between sexes at gene expression level (whole genome transcriptomics) in kidneys of F344 rats treated with 0.21 or 0.50 mg/kg bw OTA for 21 days. DNA methylation analysis of selected genes was also studied (MALDI-TOF mass spectrometry). OTA-induced response was dose-dependent in males and females, although clearer in males. Females showed a higher number of altered genes than males but functional analysis revealed a higher number of significantly enriched toxicity lists in 0.21 mg/kg treated males. OTA modulated damage, signaling and metabolism related lists, as well as inflammation, proliferation and oxidative stress in both sexes. Eleven toxicity lists (damage, fibrosis, cell signaling and metabolism) were exclusively altered in males while renal safety biomarker and biogenesis of mitochondria lists were exclusively enriched in females. A high number of lists (39) were significantly enriched in both sexes. However, they contained many sex-biased OTA-modulated genes, mainly phase I and II, transporters and nuclear receptors, but also others related to cell proliferation/apoptosis. No biologically relevant changes were observed in the methylation of selected genes.
Collapse
Affiliation(s)
- Ariane Vettorazzi
- University of Navarra, Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, E-31008, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, E-31008, Pamplona, Spain.
| | - Laura Pastor
- University of Navarra, Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, E-31008, Pamplona, Spain.
| | - Elizabeth Guruceaga
- IdiSNA, Navarra Institute for Health Research, E-31008, Pamplona, Spain; Bioinformatics Platform, Center for Applied Medical Research (CIMA), University of Navarra, E-31008, Pamplona, Spain.
| | - Adela López de Cerain
- University of Navarra, Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, E-31008, Pamplona, Spain; IdiSNA, Navarra Institute for Health Research, E-31008, Pamplona, Spain.
| |
Collapse
|
26
|
Bonilla-Ramirez L, Rios A, Quiliano M, Ramirez-Calderon G, Beltrán-Hortelano I, Franetich JF, Corcuera L, Bordessoulles M, Vettorazzi A, López de Cerain A, Aldana I, Mazier D, Pabón A, Galiano S. Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies. Eur J Med Chem 2018; 158:68-81. [PMID: 30199706 DOI: 10.1016/j.ejmech.2018.08.063] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2018] [Revised: 08/21/2018] [Accepted: 08/23/2018] [Indexed: 01/11/2023]
Abstract
Emergence of drug resistance and targeting all stages of the parasite life cycle are currently the major challenges in antimalarial chemotherapy. Molecular hybridization combining two scaffolds in a single molecule is an innovative strategy for achieving these goals. In this work, a series of novel quinoxaline 1,4-di-N-oxide hybrids containing either chloroquine or primaquine pharmacophores was designed, synthesized and tested against both chloroquine sensitive and multidrug resistant strains of Plasmodium falciparum. Only chloroquine-based compounds exhibited potent blood stage activity with compounds 4b and 4e being the most active and selective hybrids at this parasite stage. Based on their intraerythrocytic activity and selectivity or their chemical nature, seven hybrids were then evaluated against the liver stage of Plasmodium yoelii, Plasmodium berghei and Plasmodium falciparum infections. Compound 4b was the only chloroquine-quinoxaline 1,4-di-N-oxide hybrid with a moderate liver activity, whereas compound 6a and 6b were identified as the most active primaquine-based hybrids against exoerythrocytic stages, displaying enhanced liver activity against P. yoelii and P. berghei, respectively, and better SI values than primaquine. Although both primaquine-quinoxaline 1,4-di-N-oxide hybrids slightly reduced the infection of mosquitoes, they inhibited sporogony of P. berghei and compound 6a showed 92% blocking of transmission. In vivo liver efficacy assays revealed that compound 6a showed causal prophylactic activity affording parasitaemia reduction of up to 95% on day 4. Absence of genotoxicity and in vivo acute toxicity were also determined. These results suggest the approach of primaquine-quinoxaline 1,4-di-N-oxide hybrids as new potential dual-acting antimalarials for further investigation.
Collapse
Affiliation(s)
- Leonardo Bonilla-Ramirez
- Grupo Malaria, Facultad de Medicina, Universidad de Antioquía (UdeA), Sede de Investigación Universitaria (SIU), Medellín, Colombia
| | - Alexandra Rios
- Grupo Malaria, Facultad de Medicina, Universidad de Antioquía (UdeA), Sede de Investigación Universitaria (SIU), Medellín, Colombia
| | - Miguel Quiliano
- Universidad de Navarra, Institute of Tropical Health (ISTUN), Campus Universitario, 31008, Pamplona, Spain; Universidad de Navarra, Facultad de Farmacia y Nutrición, Department of Organic and Pharmaceutical Chemistry, Campus Universitario, 31008, Pamplona, Spain
| | - Gustavo Ramirez-Calderon
- Grupo Malaria, Facultad de Medicina, Universidad de Antioquía (UdeA), Sede de Investigación Universitaria (SIU), Medellín, Colombia
| | - Iván Beltrán-Hortelano
- Universidad de Navarra, Institute of Tropical Health (ISTUN), Campus Universitario, 31008, Pamplona, Spain; Universidad de Navarra, Facultad de Farmacia y Nutrición, Department of Organic and Pharmaceutical Chemistry, Campus Universitario, 31008, Pamplona, Spain
| | - Jean François Franetich
- Sorbonne Universités, UPMC Univ Paris 06, INSERM U1135, CNRS ERL, 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France
| | - Luis Corcuera
- Universidad de Navarra, Facultad de Farmacia y Nutrición, Department of Organic and Pharmaceutical Chemistry, Campus Universitario, 31008, Pamplona, Spain
| | - Mallaury Bordessoulles
- Sorbonne Universités, UPMC Univ Paris 06, INSERM U1135, CNRS ERL, 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France
| | - Ariane Vettorazzi
- Universidad de Navarra, Facultad de Farmacia y Nutrición, Department of Pharmacology and Toxicology, 31008, Pamplona, Spain
| | - Adela López de Cerain
- Universidad de Navarra, Facultad de Farmacia y Nutrición, Department of Pharmacology and Toxicology, 31008, Pamplona, Spain
| | - Ignacio Aldana
- Universidad de Navarra, Institute of Tropical Health (ISTUN), Campus Universitario, 31008, Pamplona, Spain; Universidad de Navarra, Facultad de Farmacia y Nutrición, Department of Organic and Pharmaceutical Chemistry, Campus Universitario, 31008, Pamplona, Spain
| | - Dominique Mazier
- Sorbonne Universités, UPMC Univ Paris 06, INSERM U1135, CNRS ERL, 8255, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France
| | - Adriana Pabón
- Grupo Malaria, Facultad de Medicina, Universidad de Antioquía (UdeA), Sede de Investigación Universitaria (SIU), Medellín, Colombia
| | - Silvia Galiano
- Universidad de Navarra, Institute of Tropical Health (ISTUN), Campus Universitario, 31008, Pamplona, Spain; Universidad de Navarra, Facultad de Farmacia y Nutrición, Department of Organic and Pharmaceutical Chemistry, Campus Universitario, 31008, Pamplona, Spain.
| |
Collapse
|
27
|
Enciso JM, López de Cerain A, Pastor L, Azqueta A, Vettorazzi A. Is oxidative stress involved in the sex-dependent response to ochratoxin A renal toxicity? Food Chem Toxicol 2018; 116:379-387. [DOI: 10.1016/j.fct.2018.04.050] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2018] [Revised: 04/18/2018] [Accepted: 04/20/2018] [Indexed: 11/28/2022]
|
28
|
Quiliano M, Pabón A, Moles E, Bonilla-Ramirez L, Fabing I, Fong KY, Nieto-Aco DA, Wright DW, Pizarro JC, Vettorazzi A, López de Cerain A, Deharo E, Fernández-Busquets X, Garavito G, Aldana I, Galiano S. Structure-activity relationship of new antimalarial 1-aryl-3-susbtituted propanol derivatives: Synthesis, preliminary toxicity profiling, parasite life cycle stage studies, target exploration, and targeted delivery. Eur J Med Chem 2018; 152:489-514. [PMID: 29754074 DOI: 10.1016/j.ejmech.2018.04.038] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2018] [Revised: 04/16/2018] [Accepted: 04/18/2018] [Indexed: 01/09/2023]
Abstract
Design, synthesis, structure-activity relationship, cytotoxicity studies, in silico drug-likeness, genotoxicity screening, and in vivo studies of new 1-aryl-3-substituted propanol derivatives led to the identification of nine compounds with promising in vitro (55, 56, 61, 64, 66, and 70-73) and in vivo (66 and 72) antimalarial profiles against Plasmodium falciparum and Plasmodium berghei. Compounds 55, 56, 61, 64, 66 and 70-73 exhibited potent antiplasmodial activity against chloroquine-resistant strain FCR-3 (IC50s < 0.28 μM), and compounds 55, 56, 64, 70, 71, and 72 showed potent biological activity in chloroquine-sensitive and multidrug-resistant strains (IC50s < 0.7 μM for 3D7, D6, FCR-3 and C235). All of these compounds share appropriate drug-likeness profiles and adequate selectivity indexes (77 < SI < 184) as well as lack genotoxicity. In vivo efficacy tests in a mouse model showed compounds 66 and 72 to be promising candidates as they exhibited significant parasitemia reductions of 96.4% and 80.4%, respectively. Additional studies such as liver stage and sporogony inhibition, target exploration of heat shock protein 90 of P. falciparum, targeted delivery by immunoliposomes, and enantiomer characterization were performed and strongly reinforce the hypothesis of 1-aryl-3-substituted propanol derivatives as promising antimalarial compounds.
Collapse
Affiliation(s)
- Miguel Quiliano
- Universidad de Navarra, Instituto de Salud Tropical (ISTUN), Campus Universitario, 31008 Pamplona, Spain; Universidad de Navarra, Facultad de Farmacia y Nutrición, Departamento de Química Orgánica y Farmacéutica, Campus Universitario, 31008 Pamplona, Spain
| | - Adriana Pabón
- Grupo Malaria, Universidad de Antioquía, Medellín, Colombia
| | - Ernest Moles
- Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), Baldiri Reixac 10-12, 08028 Barcelona, Spain; Barcelona Institute for Global Health (ISGlobal), Barcelona Center for International Health Research (CRESIB, Hospital Clínic-Universitat de Barcelona), Rosselló 149-153, 08036 Barcelona, Spain; Nanoscience and Nanotechnology Institute (IN2UB), University of Barcelona, Martí i Franquès 1, 08028 Barcelona, Spain
| | | | - Isabelle Fabing
- Laboratoire de Synthese et Physicochimie de Molécules d'Intéret Biologique SPCMIB-UMR5068, CNRS - Université Paul Sabatier, 118, route de Narbonne, 31062, Toulouse Cedex 09, France
| | - Kim Y Fong
- Department of Chemistry, Vanderbilt University, Station B 351822, Nashville, TN 37235, USA
| | - Diego A Nieto-Aco
- Universidad de Navarra, Instituto de Salud Tropical (ISTUN), Campus Universitario, 31008 Pamplona, Spain; Universidad de Navarra, Facultad de Farmacia y Nutrición, Departamento de Química Orgánica y Farmacéutica, Campus Universitario, 31008 Pamplona, Spain
| | - David W Wright
- Department of Chemistry, Vanderbilt University, Station B 351822, Nashville, TN 37235, USA
| | - Juan C Pizarro
- Department of Tropical Medicine, School of Public Health and Tropical Medicine, Tulane University USA; Vector-Borne Infectious Diseases Research Center, Tulane University USA
| | - Ariane Vettorazzi
- Universidad de Navarra, Facultad de Farmacia y Nutrición, Department of Pharmacology and Toxicology, Campus Universitario, 31008 Pamplona, Spain
| | - Adela López de Cerain
- Universidad de Navarra, Facultad de Farmacia y Nutrición, Department of Pharmacology and Toxicology, Campus Universitario, 31008 Pamplona, Spain
| | - Eric Deharo
- UMR 152 PHARMA-DEV, Université Toulouse, IRD, UPS, 31062, Toulouse, France
| | - Xavier Fernández-Busquets
- Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), Baldiri Reixac 10-12, 08028 Barcelona, Spain; Barcelona Institute for Global Health (ISGlobal), Barcelona Center for International Health Research (CRESIB, Hospital Clínic-Universitat de Barcelona), Rosselló 149-153, 08036 Barcelona, Spain; Nanoscience and Nanotechnology Institute (IN2UB), University of Barcelona, Martí i Franquès 1, 08028 Barcelona, Spain
| | - Giovanny Garavito
- Universidad Nacional de Colombia, Sede Bogotá, Facultad de Ciencias, Departamento de Farmacia (DFUNC), Grupo de investigación FaMeTra (Farmacología de la Medicina tradicional y popular), Carrera 30 45-03, Bogotá D.C., Colombia
| | - Ignacio Aldana
- Universidad de Navarra, Instituto de Salud Tropical (ISTUN), Campus Universitario, 31008 Pamplona, Spain; Universidad de Navarra, Facultad de Farmacia y Nutrición, Departamento de Química Orgánica y Farmacéutica, Campus Universitario, 31008 Pamplona, Spain
| | - Silvia Galiano
- Universidad de Navarra, Instituto de Salud Tropical (ISTUN), Campus Universitario, 31008 Pamplona, Spain; Universidad de Navarra, Facultad de Farmacia y Nutrición, Departamento de Química Orgánica y Farmacéutica, Campus Universitario, 31008 Pamplona, Spain.
| |
Collapse
|
29
|
Vettorazzi A, Pastor L, Cerain ALD. Sex-dependent dose response of gene expression modulation after ochratoxin A insult in F344 rats. Toxicol Lett 2017. [DOI: 10.1016/j.toxlet.2017.07.244] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
30
|
de Benito A, Ibáñez C, Moncho W, Martínez D, Vettorazzi A, de Cerain AL. Database on the taxonomical characterisation and potential toxigenic capacities of microorganisms used for the industrial production of food enzymes and feed additives, which do not have a recommendation for Qualified Presumption of Safety. EFSA Supporting Publications 2017. [PMCID: PMC7163622 DOI: 10.2903/sp.efsa.2017.en-1274] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
|
31
|
Pastor L, Vettorazzi A, Campión J, Cordero P, López de Cerain A. Gene expression kinetics of renal transporters induced by ochratoxin A in male and female F344 rats. Food Chem Toxicol 2016; 98:169-178. [PMID: 27771458 DOI: 10.1016/j.fct.2016.10.019] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2016] [Revised: 10/04/2016] [Accepted: 10/18/2016] [Indexed: 01/10/2023]
Abstract
Ochratoxin A (OTA) is a mycotoxin that contaminates foodstuffs. The most relevant concern is its high kidney carcinogenicity in male rats and its unclear mechanism of action. It has been hypothesized that variations in transport mechanisms in kidney cells may be the reason of different sex-dependent sensitivities towards OTA. The aim of this study was to analyze, by RT- qPCR, renal transporters expression in 15-week-old male (M) and female (F) F344 rats at basal level and after single oral OTA administration (0.50 mg/kg bw). Temporal profiles (24h, 48h, 72h, 96h, 1 and 2 months) were studied per sex and transporter. The reference gene for all comparisons was Ppia. At basal level, sex differences were confirmed for Oatp1, Bcrp (M>F) and Oat2 (F>M). OTA tended to inhibit the expression of almost all transporters in both sexes, but clearly induced the expression of Oat2 in males. Regarding time profiles, the highest sex differences involved Oat (Slc22) transporters: Oat2, Oat3 and Oat5 expression showed a significant increase in males (24h) while Oat1, Oat2 and Oat5 level decreased in females (48h). Overall, basal sex differences in F344 rats and the specific sex-dependent response to OTA of Oat2 might contribute to high kidney damage in male rats.
Collapse
Affiliation(s)
- Laura Pastor
- Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, University of Navarra, C/ Irunlarrea 1, 31008 Pamplona, Spain.
| | - Ariane Vettorazzi
- Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, University of Navarra, C/ Irunlarrea 1, 31008 Pamplona, Spain.
| | - Javier Campión
- Department of Food Science and Physiology, Faculty of Pharmacy and Nutrition, University of Navarra, C/ Irunlarrea 1, 31008 Pamplona, Spain; Current address: Making Genetics SL, Plaza CEIN 5, 31110 Noain, Spain.
| | - Paul Cordero
- Department of Food Science and Physiology, Faculty of Pharmacy and Nutrition, University of Navarra, C/ Irunlarrea 1, 31008 Pamplona, Spain; Current address: Institute for Liver and Digestive Health, University College London, Rowland Hill Street, London NW3 2PF, United Kingdom.
| | - Adela López de Cerain
- Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, University of Navarra, C/ Irunlarrea 1, 31008 Pamplona, Spain.
| |
Collapse
|
32
|
Quiliano M, Mendoza A, Fong KY, Pabón A, Goldfarb NE, Fabing I, Vettorazzi A, López de Cerain A, Dunn BM, Garavito G, Wright DW, Deharo E, Pérez-Silanes S, Aldana I, Galiano S. Exploring the scope of new arylamino alcohol derivatives: Synthesis, antimalarial evaluation, toxicological studies, and target exploration. Int J Parasitol Drugs Drug Resist 2016; 6:184-198. [PMID: 27718413 PMCID: PMC5061469 DOI: 10.1016/j.ijpddr.2016.09.004] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/23/2016] [Accepted: 09/26/2016] [Indexed: 01/09/2023]
Abstract
Synthesis of new 1-aryl-3-substituted propanol derivatives followed by structure-activity relationship, in silico drug-likeness, cytotoxicity, genotoxicity, in silico metabolism, in silico pharmacophore modeling, and in vivo studies led to the identification of compounds 22 and 23 with significant in vitro antiplasmodial activity against drug sensitive (D6 IC50 ≤ 0.19 μM) and multidrug resistant (FCR-3 IC50 ≤ 0.40 μM and C235 IC50 ≤ 0.28 μM) strains of Plasmodium falciparum. Adequate selectivity index and absence of genotoxicity was also observed. Notably, compound 22 displays excellent parasitemia reduction (98 ± 1%), and complete cure with all treated mice surviving through the entire period with no signs of toxicity. One important factor is the agreement between in vitro potency and in vivo studies. Target exploration was performed; this chemotype series exhibits an alternative antimalarial mechanism. New aryl-substituted propanol derivatives (APD) show promising antimalarial activity. γ-amino alcohol moiety is significant antimalarial chemotype. Compound 22 displays excellent in vivo parasitemia reduction (98%) and complete cure. APD are active against drug sensitive and multidrug resistant strains.
Collapse
Affiliation(s)
- Miguel Quiliano
- Department of Organic and Pharmaceutical Chemistry, Faculty of Pharmacy and Nutrition, University of Navarra, Pamplona, 31008, Spain; Institute of Tropical Health (ISTUN), University of Navarra, Pamplona, 31008, Spain
| | - Adela Mendoza
- Department of Organic and Pharmaceutical Chemistry, Faculty of Pharmacy and Nutrition, University of Navarra, Pamplona, 31008, Spain
| | - Kim Y Fong
- Department of Chemistry, Vanderbilt University, Station B 351822, Nashville, TN 37235, USA
| | - Adriana Pabón
- Grupo Malaria, Universidad de Antioquía, Medellín, Colombia
| | - Nathan E Goldfarb
- Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, FL, USA
| | - Isabelle Fabing
- Laboratoire de Synthèse et Physicochimie de Molécules d'Intérêt Biologique SPCMIB - UMR5068, CNRS - Université Paul Sabatier, 118, route de Narbonne, 31062, Toulouse Cedex 09, France
| | - Ariane Vettorazzi
- Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, University of Navarra, Pamplona, 31008, Spain
| | - Adela López de Cerain
- Department of Pharmacology and Toxicology, Faculty of Pharmacy and Nutrition, University of Navarra, Pamplona, 31008, Spain
| | - Ben M Dunn
- Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, FL, USA
| | - Giovanny Garavito
- Universidad Nacional de Colombia, Sede Bogotá, Facultad de Ciencias, Departamento de Farmacia (DFUNC), Grupo de investigación FaMeTra (Farmacología de la Medicina tradicional y popular), Carrera 30 45-03, Bogotá D.C., Colombia
| | - David W Wright
- Department of Chemistry, Vanderbilt University, Station B 351822, Nashville, TN 37235, USA
| | - Eric Deharo
- UMR 152 PHARMA-DEV, Université Toulouse, IRD, UPS, 31062, Toulouse, France
| | - Silvia Pérez-Silanes
- Department of Organic and Pharmaceutical Chemistry, Faculty of Pharmacy and Nutrition, University of Navarra, Pamplona, 31008, Spain; Institute of Tropical Health (ISTUN), University of Navarra, Pamplona, 31008, Spain
| | - Ignacio Aldana
- Department of Organic and Pharmaceutical Chemistry, Faculty of Pharmacy and Nutrition, University of Navarra, Pamplona, 31008, Spain; Institute of Tropical Health (ISTUN), University of Navarra, Pamplona, 31008, Spain
| | - Silvia Galiano
- Department of Organic and Pharmaceutical Chemistry, Faculty of Pharmacy and Nutrition, University of Navarra, Pamplona, 31008, Spain; Institute of Tropical Health (ISTUN), University of Navarra, Pamplona, 31008, Spain.
| |
Collapse
|
33
|
Pastor L, Vettorazzi A, Enciso J, López de Cerain A. Sex-dependent changes of kidney transporters expression after repeated oral administration of ochratoxin A in F344 rats. Toxicol Lett 2015. [DOI: 10.1016/j.toxlet.2015.08.843] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
34
|
Corcuera LA, Vettorazzi A, Arbillaga L, Pérez N, Gil AG, Azqueta A, González-Peñas E, García-Jalón JA, López de Cerain A. Genotoxicity of Aflatoxin B1 and Ochratoxin A after simultaneous application of the in vivo micronucleus and comet assay. Food Chem Toxicol 2014; 76:116-24. [PMID: 25530104 DOI: 10.1016/j.fct.2014.12.003] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2014] [Revised: 11/20/2014] [Accepted: 12/03/2014] [Indexed: 10/24/2022]
Abstract
Aflatoxin B1 (AFB1) and Ochratoxin A (OTA) are genotoxic mycotoxins that can contaminate a variety of foodstuffs, the liver and the kidney being their target organs, respectively. The micronucleus (MN) assay (bone marrow) and the comet assay (liver and kidney) were performed simultaneously in F344 rats, treated with AFB1 (0.25 mg/kg b.w.), OTA (0.5 mg/kg b.w.) or both mycotoxins. After AFB1 treatment, histopathology and biochemistry analysis showed liver necrosis, focal inflammation and an increase in Alanine Aminotransferase and Aspartate Aminotransferase. OTA alone did not cause any alteration. The acute hepatotoxic effects caused by AFB1 were less pronounced in animals treated with both mycotoxins. With regard to the MN assay, after 24 h, positive results were obtained for AFB1 and negative results were obtained for OTA, although both toxins caused bone marrow toxicity. In the combined treatment, OTA reduced the toxicity and the number of MN produced by AFB1. In the comet assay, after 3 h, positive results were obtained for AFB1 in the liver and for OTA in the kidney. The combined treatment reduced DNA damage in the liver and had no influence in the kidney. Altogether, these results may be indicative of an antagonistic relationship regarding the genotoxicity of both mycotoxins.
Collapse
Affiliation(s)
- Laura-Ana Corcuera
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Navarra, Irunlarrea 1, 31008 Pamplona, Spain
| | - Ariane Vettorazzi
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Navarra, Irunlarrea 1, 31008 Pamplona, Spain
| | - Leire Arbillaga
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Navarra, Irunlarrea 1, 31008 Pamplona, Spain
| | - Noemí Pérez
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Navarra, Irunlarrea 1, 31008 Pamplona, Spain
| | - Ana Gloria Gil
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Navarra, Irunlarrea 1, 31008 Pamplona, Spain
| | - Amaya Azqueta
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Navarra, Irunlarrea 1, 31008 Pamplona, Spain
| | - Elena González-Peñas
- Department of Organic and Pharmaceutical Chemistry, Faculty of Pharmacy, University of Navarra, Irunlarrea 1, 31008, Pamplona, Spain
| | - Jose Antonio García-Jalón
- Department of Animal Pathology, Faculty of Veterinary, University of Zaragoza, C/Miguel Servet 177, 50013 Zaragoza, Spain
| | - Adela López de Cerain
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Navarra, Irunlarrea 1, 31008 Pamplona, Spain.
| |
Collapse
|
35
|
Vettorazzi A, González-Peñas E, de Cerain AL. Ochratoxin A kinetics: A review of analytical methods and studies in rat model. Food Chem Toxicol 2014; 72:273-88. [DOI: 10.1016/j.fct.2014.07.020] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2014] [Revised: 07/04/2014] [Accepted: 07/13/2014] [Indexed: 10/25/2022]
|
36
|
Pastor L, Vettorazzi A, de Cerain AL. Sex-dependent gene expression of kidney transporters after Ochratoxin A exposure in F344 rats. Toxicol Lett 2014. [DOI: 10.1016/j.toxlet.2014.06.297] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
37
|
Vettorazzi A, Wait R, Nagy J, Monreal JI, Mantle P. Changes in male rat urinary protein profile during puberty: a pilot study. BMC Res Notes 2013; 6:232. [PMID: 23767887 PMCID: PMC3751546 DOI: 10.1186/1756-0500-6-232] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2013] [Accepted: 06/03/2013] [Indexed: 01/25/2023] Open
Abstract
Background Androgen-dependent proteins (lipocalins) circulate in blood of male rats and mice and, being small (~ 18 kDa), pass freely into glomerular filtrate. Some are salvaged in proximal nephrons but some escape in urine. Several organic molecules can bind to these proteins causing, where salvage occurs, nephropathy including malignancy in renal cortex. In urine, both free lipocalins and ligands contribute to an increasingly-recognised vital biological role in social communication between adults, especially in the dark where reliance is on smell and taste. Crystal structure of the first-characterised lipocalin of male rats, α2u-globulin, has been determined and peptide sequences for others are available, but no study of occurrence during early puberty has been made. We have followed temporal occurrence in urine of juveniles (n = 3) for non-invasive pilot study by high resolution gradient mini-gel electrophoresis, tryptic digest of excised protein bands, and LC-MS/MS of digest to identify peptide fragments and assign to specific lipocalins. Study objective refers directly to external availability for social communication but also indirectly to indicate kinetics of circulating lipocalins to which some xenobiotics may bind and constitute determinants of renal disease. Results Mini-gels revealed greater lipocalin complexity than hitherto recognised, possibly reflecting post-translational modifications. Earliest patterns comprised rat urinary protein 1, already evident in Sprague-Dawley and Wistar strains at 36 and 52 days, respectively. By 44 and 57 days major rat protein (α2u-globulin) occurred as the progressively more dominant protein, though as two forms with different electrophoretic mobility, characterised by seven peptide sequences. No significant change in urinary testosterone had occurred in Wistars when major rat protein became evident, but testosterone surged by 107 days concomitant with the marked abundance of excreted lipocalins. Conclusions Qualitative temporal changes in the composition of excreted lipocalins early in puberty, and apparent increase in major urinary protein as two resolvable forms, should catalyse systematic non-invasive study of urinary lipocalin and testosterone dynamics from early age, to illuminate this aspect of laboratory rodent social physiology. It could also define the potential temporal onset of nephrotoxic ligand risk, applicable to young animals used as toxicological models.
Collapse
|
38
|
Corcuera L, Vettorazzi A, Arbillaga L, González-Peñas E, López de Cerain A. An approach to the toxicity and toxicokinetics of aflatoxin B1 and ochratoxin A after simultaneous oral administration to fasted F344 rats. Food Chem Toxicol 2012; 50:3440-6. [DOI: 10.1016/j.fct.2012.06.048] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2012] [Revised: 06/25/2012] [Accepted: 06/26/2012] [Indexed: 11/29/2022]
|
39
|
Corcuera LA, Amézqueta S, Arbillaga L, Vettorazzi A, Touriño S, Torres JL, López de Cerain A. A polyphenol-enriched cocoa extract reduces free radicals produced by mycotoxins. Food Chem Toxicol 2011; 50:989-95. [PMID: 22166788 DOI: 10.1016/j.fct.2011.11.052] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2011] [Revised: 11/24/2011] [Accepted: 11/28/2011] [Indexed: 11/25/2022]
Abstract
Polyphenols are characterized by the presence of phenol units in the molecules. These compounds may show antioxidant ability by scavenging reactive oxygen species (ROS) of the free radical type. A polyphenol enriched cocoa extract (PECE) was obtained from cocoa seeds with 28% of procyanidins which were mainly epicatechin oligomers. PECE was very active as free radical scavenger against 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid (ABTS), 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) and tris(2,4,6-trichloro-3,5-dinitrophenyl)methyl (HNTTM) radicals; and the tris(2,3,5,6-tetrachloro-4-nitrophenyl)methyl (TNPTM) assay showed that the PECE might not be pro-oxidant. Thus it was considered a good candidate to be tested in in vitro models. It showed mild cytotoxic power on Hep G2 cells and induced ROS in a dose-dependent manner being weak oxidant only at high concentrations near the limit of solubility. The antioxidant properties were assayed in Hep G2 treated with the mycotoxins ochratoxin A (OTA) and/or aflatoxin B1 (AFB1). The PECE was not effective against AFB1 but it increased the cell viability and reduced significantly the amounts of ROS in cells treated with OTA or mixtures of AFB1+OTA. These results are coherent with the role of oxidative pathways in the mechanism of OTA and indicate that polyphenols extracted from cocoa may be good candidates as antioxidant agents.
Collapse
Affiliation(s)
- L A Corcuera
- Department of Nutrition and Food Sciences, Physiology and Toxicology, Faculty of Pharmacy, University of Navarra, Irunlarrea 1, E-31008 Pamplona, Spain.
| | | | | | | | | | | | | |
Collapse
|
40
|
Corcuera LA, Ibáñez-Vea M, Vettorazzi A, González-Peñas E, Cerain ALD. Validation of a UHPLC-FLD analytical method for the simultaneous quantification of aflatoxin B1 and ochratoxin a in rat plasma, liver and kidney. J Chromatogr B Analyt Technol Biomed Life Sci 2011; 879:2733-40. [DOI: 10.1016/j.jchromb.2011.07.039] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2011] [Revised: 07/29/2011] [Accepted: 07/31/2011] [Indexed: 11/25/2022]
|
41
|
Vettorazzi A, de Trocóniz IF, González-Peñas E, Arbillaga L, Corcuera LA, Gil AG, de Cerain AL. Kidney and liver distribution of ochratoxin A in male and female F344 rats. Food Chem Toxicol 2011; 49:1935-42. [DOI: 10.1016/j.fct.2011.04.021] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2010] [Revised: 03/01/2011] [Accepted: 04/19/2011] [Indexed: 10/18/2022]
|
42
|
Cabrera M, López GV, Gómez LE, Breijo M, Pintos C, Botti H, Raymondo S, Vettorazzi A, Ceráin ALD, Monge A, Rubbo H, González M, Cerecetto H. Genetic toxicology and preliminaryin vivostudies of nitric oxide donor tocopherol analogs as potential new class of antiatherogenic agents. Drug Chem Toxicol 2011; 34:285-93. [DOI: 10.3109/01480545.2010.536769] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
43
|
Vettorazzi A, Trocóniz IF, Gonzalez-Peñas E, Corcuera LA, Arbillaga L, Gil AG, Nagy JM, Mantle PG, de Cerain AL. Effects of fasting and gender on ochratoxin A toxicokinetics in F344 rats. Food Chem Toxicol 2010; 48:3159-66. [PMID: 20728502 DOI: 10.1016/j.fct.2010.08.012] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2010] [Revised: 06/04/2010] [Accepted: 08/15/2010] [Indexed: 11/30/2022]
Abstract
Ochratoxin A (OTA) is a mycotoxin that causes renal tumors in rats, particularly in males. In previous kinetic studies performed in fed conditions (Vettorazzi et al., 2008), mature F344 male rats presented a significantly lower OTA bioavailability than females and young animals. The objective of the present study was to evaluate two factors which could explain this different kinetic profile: the presence of food and the male-specific protein alpha-2u-globulin. Therefore, a 24h kinetic study has been performed in rats under fasting conditions. Food ingestion has been controlled in both sexes during two months. The presence of alpha-2u-globulin in the urine has been analyzed with SDS-gradient mini-gel electrophoresis. Fasting tends to increase the maximum OTA plasma concentrations and the rate of absorption. The relative bioavailability is significantly increased under fasting conditions only in males. Mature males consumed a higher amount of food but, as the OTA dose administered, it was proportional to body weight. The reason why the OTA bioavailability is more affected in presence of food only in males is unclear. Several possibilities, such as differences in gastric emptying, OTA-food interactions and the involvement of alpha-2u-globulin are discussed.
Collapse
Affiliation(s)
- A Vettorazzi
- Department of Nutrition and Food Sciences, Physiology and Toxicology, Faculty of Pharmacy, University of Navarra, Pamplona, Spain
| | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Vettorazzi A, Gonzalez-Peñas E, Trocóniz I, Arbillaga L, Corcuera L, Gil A, López de Cerain A. A different kinetic profile of ochratoxin A in mature male rats. Food Chem Toxicol 2009; 47:1921-7. [PMID: 19445996 DOI: 10.1016/j.fct.2009.05.003] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2009] [Revised: 04/30/2009] [Accepted: 05/07/2009] [Indexed: 10/20/2022]
|
45
|
Vettorazzi A, Gonzalez-Peñas E, Arbillaga L, Corcuera LA, López de Cerain A. Simple high-performance liquid chromatography—fluorescence detection method for plasma, kidney and liver of rat as a tool for toxicology studies. J Chromatogr A 2008; 1215:100-6. [DOI: 10.1016/j.chroma.2008.10.119] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2008] [Revised: 10/25/2008] [Accepted: 10/31/2008] [Indexed: 11/26/2022]
|
46
|
Arbillaga L, Vettorazzi A, Gil AG, van Delft JHM, García-Jalón JA, López de Cerain A. Gene expression changes induced by ochratoxin A in renal and hepatic tissues of male F344 rat after oral repeated administration. Toxicol Appl Pharmacol 2008; 230:197-207. [PMID: 18417182 DOI: 10.1016/j.taap.2008.02.018] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2007] [Revised: 02/20/2008] [Accepted: 02/25/2008] [Indexed: 10/22/2022]
|
47
|
Arbillaga L, Vettorazzi A, Gil AG, de Cerain AL. Ochratoxin A-induced renal gene expression changes in F344 rats after repeated oral administration. Toxicol Lett 2007. [DOI: 10.1016/j.toxlet.2007.05.480] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
48
|
Vettorazzi A, Arbillaga L, Gil AG, González-Peñas E, de Cerain AL. Influence of the vehicle in the distribution and accumulation of ochratoxin A after oral administration in F-344 rats. Toxicol Lett 2007. [DOI: 10.1016/j.toxlet.2007.05.514] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|